Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130443&wire=1 or contact Joseph E. Levi, Esq.
- 02/18/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130340&wire=1 or contact Joseph E. Levi, Esq.
- 02/18/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
- NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130271&wire=1 or contact Joseph E. Levi, Esq.
- 02/18/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130235&wire=1 or contact Joseph E. Levi, Esq.
- 02/18/2025
|
APLT DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 18, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 02/18/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
- NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130186&wire=1 or contact Joseph E. Levi, Esq.
- 02/18/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
- NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130160&wire=1 or contact Joseph E. Levi, Esq.
- 02/18/2025
|
FINAL REMINDER APLT DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Applied Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit
- NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/18/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK , Feb. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 02/18/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Shareholders
- NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130109&wire=1 or contact Joseph E. Levi, Esq.
- 02/17/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130095&wire=1 or contact Joseph E. Levi, Esq.
- 02/17/2025
|
APLT COURT NOTIFICATION: Suffer Losses on Applied Therapeutics? Contact BFA Law by Tomorrow's Class Action Deadline
- NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/17/2025
|
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130067&wire=1 or contact Joseph E. Levi, Esq.
- 02/17/2025
|
APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
- NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 02/17/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130020&wire=1 or contact Joseph E. Levi, Esq.
- 02/17/2025
|
DEADLINE APPROACHING: Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / February 17, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/17/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - APLT
- NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=130015&wire=1 or contact Joseph E. Levi, Esq.
- 02/17/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129983&wire=1 or contact Joseph E. Levi, Esq.
- 02/17/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129955&wire=1 or contact Joseph E. Levi, Esq.
- 02/17/2025
|
FINAL APLT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Applied Therapeutics, Inc. Investors to Join the Class Action Lawsuit
- NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/17/2025
|
INVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLT
- SAN DIEGO , Feb. 17, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), have until this upcoming Tuesday, February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v.
- 02/17/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129938&wire=1 or contact Joseph E. Levi, Esq.
- 02/16/2025
|
APLT Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
- RADNOR, Pa. , Feb. 16, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period").
- 02/16/2025
|
Investors who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129911&wire=1 or contact Joseph E. Levi, Esq.
- 02/16/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129905&wire=1 or contact Joseph E. Levi, Esq.
- 02/16/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129875&wire=1 or contact Joseph E. Levi, Esq.
- 02/16/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / February 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/16/2025
|
APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit
- NEW YORK , Feb. 16, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. So what: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 02/16/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129852&wire=1 or contact Joseph E. Levi, Esq.
- 02/16/2025
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Applied Therapeutics To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / February 16, 2025 / If you purchased or acquired securities in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT) and reminds investors of the February 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 02/16/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129815&wire=1 or contact Joseph E. Levi, Esq.
- 02/16/2025
|
APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT)
- NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/16/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Applied Therapeutics, Inc. to Contact the Firm Today!
- NEW YORK, NY / ACCESS Newswire / February 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/16/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – APLT
- NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129783&wire=1 or contact Joseph E. Levi, Esq.
- 02/15/2025
|
APLT DEADLINE TUESDAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 02/15/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
- NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129739&wire=1 or contact Joseph E. Levi, Esq.
- 02/15/2025
|
APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights
- NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024. Applied Therapeutics is a clinical-stage biopharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that.
- 02/15/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / February 15, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/15/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESS Newswire / February 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 02/15/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129713&wire=1 or contact Joseph E. Levi, Esq.
- 02/14/2025
|
APLT DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
- NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 02/14/2025
|
Deadline Soon: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming February 18, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON APPLIED THERAPEUTICS, INC. (APLT), CLIC.
- 02/14/2025
|
Lost Money on Applied Therapeutics, Inc. (APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129603&wire=1 or contact Joseph E. Levi, Esq.
- 02/14/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / February 14, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/14/2025
|
APLT Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
- RADNOR, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.
- 02/14/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129599&wire=1 or contact Joseph E. Levi, Esq.
- 02/14/2025
|
APLT FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 14, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 02/14/2025
|
APLT COURT ALERT: Applied Therapeutics Investors are Notified of Imminent February 18 Deadline; Contact BFA Law if You Incurred Losses
- NEW YORK CITY, NY / ACCESS Newswire / February 14, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/14/2025
|
Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129497&wire=1 or contact Joseph E. Levi, Esq.
- 02/14/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129477&wire=1 or contact Joseph E. Levi, Esq.
- 02/14/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Applied Therapeutics, Inc. to Contact the Firm Today!
- NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/14/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 02/14/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129403&wire=1 or contact Joseph E. Levi, Esq.
- 02/13/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129395&wire=1 or contact Joseph E. Levi, Esq.
- 02/13/2025
|
APLT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 02/13/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129377&wire=1 or contact Joseph E. Levi, Esq.
- 02/13/2025
|
Applied Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 18, 2025 Deadline to file Lead Plaintiff Motion.
- Investors can contact the law firm at no cost to learn more about recovering their losses
- 02/13/2025
|
APLT SHAREHOLDER NOTE: Lose Money on Applied Therapeutics? Contact BFA Law before February 18 Class Action Deadline
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/13/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129339&wire=1 or contact Joseph E. Levi, Esq.
- 02/13/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.
- 02/13/2025
|
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). IF YOU SUFFERED A LOSS ON YOUR APPLIED THERAPEUTICS INVESTMENTS, CLICK HERE BEFORE FEBRUARY 18, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
- 02/13/2025
|
Shareholders That Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129315&wire=1 or contact Joseph E. Levi, Esq.
- 02/13/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/13/2025
|
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129299&wire=1 or contact Joseph E. Levi, Esq.
- 02/13/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129288&wire=1 or contact Joseph E. Levi, Esq.
- 02/13/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 02/13/2025
|
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLT
- SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”), have until Tuesday, February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v. Applied Therapeutics, Inc., No. 24-cv-09715 (S.D.N.Y.), the Applied Therapeutics class action lawsuit charges Applied Therapeutics and certain of Applied Therapeutics' executives with violations of the Securities Exchange Act of 1934.
- 02/13/2025
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129189&wire=1 or contact Joseph E. Levi, Esq.
- 02/13/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Applied Therapeutics, Inc. to Contact the Firm Today!
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/13/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK , Feb. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 02/13/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129118&wire=1 or contact Joseph E. Levi, Esq.
- 02/12/2025
|
APLT DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 12, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 02/12/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129080&wire=1 or contact Joseph E. Levi, Esq.
- 02/12/2025
|
APLT SHAREHOLDER NEWS: Applied Therapeutics Investors that Lost Money may have been affected by Fraud - Contact BFA Law by February 18 Deadline
- NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/12/2025
|
APLT LAWSUIT ALERT: The Gross Law Firm Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT).
- 02/12/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129056&wire=1 or contact Joseph E. Levi, Esq.
- 02/12/2025
|
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- BENSALEM, Pa. , Feb. 12, 2025 /PRNewswire/ -- The Law Offices of Howard G.
- 02/12/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129028&wire=1 or contact Joseph E. Levi, Esq.
- 02/12/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / February 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/12/2025
|
APLT Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
- RADNOR, PA / ACCESS Newswire / February 12, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ:APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period"). The lead plaintiff deadline is February 18, 2025.
- 02/12/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128993&wire=1 or contact Joseph E. Levi, Esq.
- 02/12/2025
|
Investors who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128928&wire=1 or contact Joseph E. Levi, Esq.
- 02/12/2025
|
APLT CLASS ACTION REPORT: Applied Therapeutics is being Sued for Securities Fraud; Investors are Urged to Contact BFA Law by February 18 Deadline (NASDAQ:APLT)
- NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/12/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128900&wire=1 or contact Joseph E. Levi, Esq.
- 02/12/2025
|
APLT Stockholders Have Opportunity to Lead Applied Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/12/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128844&wire=1 or contact Joseph E. Levi, Esq.
- 02/11/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 02/11/2025
|
APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit
- NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. So what: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 02/11/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128800&wire=1 or contact Joseph E. Levi, Esq.
- 02/11/2025
|
APLT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
- NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 02/11/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / February 11, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/11/2025
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128783&wire=1 or contact Joseph E. Levi, Esq.
- 02/11/2025
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128740&wire=1 or contact Joseph E. Levi, Esq.
- 02/11/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/11/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 02/11/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128702&wire=1 or contact Joseph E. Levi, Esq.
- 02/11/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128668&wire=1 or contact Joseph E. Levi, Esq.
- 02/11/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
- NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128636&wire=1 or contact Joseph E. Levi, Esq.
- 02/11/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128591&wire=1 or contact Joseph E. Levi, Esq.
- 02/10/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128559&wire=1 or contact Joseph E. Levi, Esq.
- 02/10/2025
|
APLT DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Deadline and Encourages Investors with Losses to Contact the Firm
- RADNOR, Pa. , Feb. 10, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period").
- 02/10/2025
|
APLT FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Rosen Law Firm PA WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 02/10/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit – APLT
- NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128533&wire=1 or contact Joseph E. Levi, Esq.
- 02/10/2025
|
ENPH IMPORTANT DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Important February 11 Deadline in Securities Class Action – ENPH
- NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Enphase Energy, Inc. (NASDAQ: ENPH) between April 25, 2023 and October 22, 2024, both dates inclusive (the “Class Period”), of the important February 11, 2025 lead plaintiff deadline.
- 02/10/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128501&wire=1 or contact Joseph E. Levi, Esq.
- 02/10/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
- 02/10/2025
|
APLT CLASS ACTION NEWS: Applied Therapeutics has been Sued for Securities Fraud - Contact BFA Law by February 18 if you Suffered Losses
- NEW YORK, NY / ACCESSWIRE / February 10, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/10/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 – APLT
- NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.
- 02/10/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128460&wire=1 or contact Joseph E. Levi, Esq.
- 02/10/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128446&wire=1 or contact Joseph E. Levi, Esq.
- 02/10/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128433&wire=1 or contact Joseph E. Levi, Esq.
- 02/10/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/10/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128368&wire=1 or contact Joseph E. Levi, Esq.
- 02/10/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128347&wire=1 or contact Joseph E. Levi, Esq.
- 02/10/2025
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/10/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128304&wire=1 or contact Joseph E. Levi, Esq.
- 02/09/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128262&wire=1 or contact Joseph E. Levi, Esq.
- 02/09/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / February 9, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/09/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128209&wire=1 or contact Joseph E. Levi, Esq.
- 02/09/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 02/09/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc.(APLT)
- NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128188&wire=1 or contact Joseph E. Levi, Esq.
- 02/09/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128155&wire=1 or contact Joseph E. Levi, Esq.
- 02/09/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/09/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / February 8, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128085&wire=1 or contact Joseph E. Levi, Esq.
- 02/08/2025
|
APLT DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Applied Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
- NEW YORK, Feb. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 02/08/2025
|
APLT Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT)
- RADNOR, Pa., Feb. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.
- 02/08/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / February 8, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/08/2025
|
APLT CLASS ACTION ALERT: A Class Action has been filed on behalf of Applied Therapeutics Investors – Contact BFA Law by February 18 (NASDAQ:APLT)
- NEW YORK, Feb. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/08/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128040&wire=1 or contact Joseph E. Levi, Esq.
- 02/07/2025
|
APLT DEADLINE NOTICE: Lose Money on Applied Therapeutics? Contact BFA Law about the Pending Class Action before February 18 Deadline
- NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/07/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128022&wire=1 or contact Joseph E. Levi, Esq.
- 02/07/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit – APLT
- NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.
- 02/07/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127970&wire=1 or contact Joseph E. Levi, Esq.
- 02/07/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / February 7, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/07/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127954&wire=1 or contact Joseph E. Levi, Esq.
- 02/07/2025
|
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Applied Therapeutics To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Feb. 7, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) and reminds investors of the February 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 02/07/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127917&wire=1 or contact Joseph E. Levi, Esq.
- 02/07/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 02/07/2025
|
Shareholders That Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127827&wire=1 or contact Joseph E. Levi, Esq.
- 02/07/2025
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127801&wire=1 or contact Joseph E. Levi, Esq.
- 02/07/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/07/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127666&wire=1 or contact Joseph E. Levi, Esq.
- 02/06/2025
|
Applied Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 18, 2025 Deadline to file Lead Plaintiff Motion.
- Investors can contact the law firm at no cost to learn more about recovering their losses
- 02/06/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127654&wire=1 or contact Joseph E. Levi, Esq.
- 02/06/2025
|
APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit
- NEW YORK , Feb. 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. So what: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 02/06/2025
|
APLT LAWSUIT ALERT: The Gross Law Firm Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT).
- 02/06/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127630&wire=1 or contact Joseph E. Levi, Esq.
- 02/06/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Shareholders
- NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127596&wire=1 or contact Joseph E. Levi, Esq.
- 02/06/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127594&wire=1 or contact Joseph E. Levi, Esq.
- 02/06/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / February 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/06/2025
|
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, PA / ACCESS Newswire / February 6, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ:APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period"). The lead plaintiff deadline is February 18, 2025.
- 02/06/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127498&wire=1 or contact Joseph E. Levi, Esq.
- 02/06/2025
|
APLT DEADLINE APPROACHING: BFA Law Notifies Applied Therapeutics Investors to Contact the Firm before the Upcoming February 18 Class Action Deadline (NASDAQ:APLT)
- NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/06/2025
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / February 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/06/2025
|
The Gross Law Firm Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK , Feb. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 02/06/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127431&wire=1 or contact Joseph E. Levi, Esq.
- 02/05/2025
|
APLT DEADLINE NOTIFICATION: A Class Action Lawsuit was filed against Applied Therapeutics -- Investors are Urged to Contact BFA Law before February 18 Deadline
- NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/05/2025
|
Lost Money on Applied Therapeutics, Inc. (APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127411&wire=1 or contact Joseph E. Levi, Esq.
- 02/05/2025
|
ROSEN, LEADING INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 02/05/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127386&wire=1 or contact Joseph E. Levi, Esq.
- 02/05/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127373&wire=1 or contact Joseph E. Levi, Esq.
- 02/05/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / February 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127347&wire=1 or contact Joseph E. Levi, Esq.
- 02/05/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 02/05/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And The Schall Law Firm Urges Investors With Losses To Reach Out
- LOS ANGELES, CA / ACCESS Newswire / February 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/05/2025
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Applied Therapeutics To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / February 5, 2025 / If you purchased or acquired securities in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT) and reminds investors of the February 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 02/05/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information – APLT
- NEW YORK, NY / ACCESS Newswire / February 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127251&wire=1 or contact Joseph E. Levi, Esq.
- 02/05/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127248&wire=1 or contact Joseph E. Levi, Esq.
- 02/05/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/05/2025
|
Investors who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky about Pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127198&wire=1 or contact Joseph E. Levi, Esq.
- 02/04/2025
|
ROSEN, A TOP RANKED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 02/04/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127142&wire=1 or contact Joseph E. Levi, Esq.
- 02/04/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
- 02/04/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127116&wire=1 or contact Joseph E. Levi, Esq.
- 02/04/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK , Feb. 4, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 02/04/2025
|
APLT COURT DEADLINE: Applied Therapeutics Investors are Notified to Contact BFA Law before Feb-ruary 18 Deadline in Securities Fraud Class Action
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/04/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127093&wire=1 or contact Joseph E. Levi, Esq.
- 02/04/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127066&wire=1 or contact Joseph E. Levi, Esq.
- 02/04/2025
|
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , Feb. 4, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) have opportunity to lead the securities fraud class action lawsuit.
- 02/04/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.
- 02/04/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127046&wire=1 or contact Joseph E. Levi, Esq.
- 02/04/2025
|
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Applied Therapeutics To Contact Him Directly To Discuss Their Options
- 02/04/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127029&wire=1 or contact Joseph E. Levi, Esq.
- 02/04/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=127018&wire=1 or contact Joseph E. Levi, Esq.
- 02/04/2025
|
APLT CLASS ACTION DEADLINE: The Applied Therapeutics Court Deadline is Approaching – Contact BFA Law by February 18 (NASDAQ:APLT)
- NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/04/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc.(APLT)
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126989&wire=1 or contact Joseph E. Levi, Esq.
- 02/04/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/04/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK , Feb. 4, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 02/04/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126952&wire=1 or contact Joseph E. Levi, Esq.
- 02/03/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126923&wire=1 or contact Joseph E. Levi, Esq.
- 02/03/2025
|
Kirby McInerney LLP Urges Investors in Applied Therapeutics, Inc. (APLT) to Inquire About Their Rights in Class Action Lawsuit
- NEW YORK--(BUSINESS WIRE)---- $APLT #CLASSACTIONLAWSUIT--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT) securities between January 3, 2024, to December 2, 2024 (“the Class Period”). Investors have until February 18, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit. [LEAR.
- 02/03/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126907&wire=1 or contact Joseph E. Levi, Esq.
- 02/03/2025
|
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025. CONTACT KESSLER TOPAZ MELTZER &.
- 02/03/2025
|
Applied Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; February 18, 2025 Deadline to file Lead Plaintiff Motion
- Investors can contact the law firm at no cost to learn more about recovering their losses
- 02/03/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126885&wire=1 or contact Joseph E. Levi, Esq.
- 02/03/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126837&wire=1 or contact Joseph E. Levi, Esq.
- 02/03/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126811&wire=1 or contact Joseph E. Levi, Esq.
- 02/03/2025
|
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
- NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT).
- 02/03/2025
|
Shareholders With Losses Have Opportunity To Lead The Schall Law Firm In A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / February 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/03/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126724&wire=1 or contact Joseph E. Levi, Esq.
- 02/03/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126700&wire=1 or contact Joseph E. Levi, Esq.
- 02/03/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/03/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - APLT
- NEW YORK , Feb. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 02/03/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126665&wire=1 or contact Joseph E. Levi, Esq.
- 02/02/2025
|
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Feb. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 02/02/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / February 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126656&wire=1 or contact Joseph E. Levi, Esq.
- 02/02/2025
|
Kessler Topaz Meltzer & Check, LLP - APLT Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT)
- RADNOR, Pa., Feb. 02, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.
- 02/02/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESS Newswire / February 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126609&wire=1 or contact Joseph E. Levi, Esq.
- 02/02/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/02/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / February 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126548&wire=1 or contact Joseph E. Levi, Esq.
- 02/02/2025
|
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Applied Therapeutics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Feb. 2, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) and reminds investors of the February 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 02/02/2025
|
APLT FRAUD REMINDER: A Class Action Lawsuit has been Filed against Applied Therapeutics for Fraud – Contact BFA Law before February 18 Deadline (NASDAQ:APLT)
- NEW YORK, Feb. 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 02/02/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
- NEW YORK, NY / ACCESS Newswire / February 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126526&wire=1 or contact Joseph E. Levi, Esq.
- 02/02/2025
|
APLT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 02/02/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 1, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126483&wire=1 or contact Joseph E. Levi, Esq.
- 02/01/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – APLT
- NEW YORK, NY / ACCESS Newswire / February 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 02/01/2025
|
SHAREHOLDER ALERT: The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 02/01/2025
|
ROSEN, LEADING INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / February 1, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 02/01/2025
|
APLT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
- SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), have until Tuesday, February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v. Applied Therapeutics, Inc., No. 24-cv-09715 (S.D.N.Y.), the Applied Therapeutics class action lawsuit charges Applied Therapeutics as well as certain of Applied Therapeutics' top executives with violations of the Securities Exchange Act of 1934.
- 01/31/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – APLT
- NEW YORK, NY / ACCESS Newswire / January 31, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126447&wire=1 or contact Joseph E. Levi, Esq.
- 01/31/2025
|
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit
- NEW YORK , Jan. 31, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. So what: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/31/2025
|
Investors who lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / January 31, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126417&wire=1 or contact Joseph E. Levi, Esq.
- 01/31/2025
|
APLT FRAUD NOTICE: Applied Therapeutics Investors Alerted of Class Action Lawsuit after the Stock Plummeted 80% - Contact BFA Law by February 18 Court Deadline
- NEW YORK, NY / ACCESS Newswire / January 31, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/31/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / January 31, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126369&wire=1 or contact Joseph E. Levi, Esq.
- 01/31/2025
|
APLT SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Applied Therapeutics, Inc. (APLT)
- RADNOR, PA / ACCESS Newswire / January 31, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ:APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period"). The lead plaintiff deadline is February 18, 2025.
- 01/31/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / January 31, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126341&wire=1 or contact Joseph E. Levi, Esq.
- 01/31/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 31, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/31/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / January 31, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126320&wire=1 or contact Joseph E. Levi, Esq.
- 01/31/2025
|
Faruqi & Faruqi Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 deadline - APLT
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Applied Therapeutics To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / January 31, 2025 / If you purchased or acquired securities in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT) and reminds investors of the February 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 01/31/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / January 31, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126252&wire=1 or contact Joseph E. Levi, Esq.
- 01/31/2025
|
APLT FRAUD ALERT: Applied Therapeutics Sued for Securities Fraud after Stock Drops 80% – Investors Urged to Contact BFA Law by February 18 Deadline (NASDAQ:APLT)
- NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/31/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 31, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126225&wire=1 or contact Joseph E. Levi, Esq.
- 01/31/2025
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / January 31, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/31/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK , Jan. 31, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 01/31/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / January 30, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126170&wire=1 or contact Joseph E. Levi, Esq.
- 01/30/2025
|
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 01/30/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, NY / ACCESS Newswire / January 30, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126131&wire=1 or contact Joseph E. Levi, Esq.
- 01/30/2025
|
APLT INVESTOR ALERT: Kirby McInerney LLP Notifies Applied Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
- NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the February 18, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT) securities during the period from January 3, 2024, through December 2, 2024 (“the Class Period”).
- 01/30/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – APLT
- NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.
- 01/30/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / January 30, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126097&wire=1 or contact Joseph E. Levi, Esq.
- 01/30/2025
|
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , Jan. 30, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). IF YOU SUFFERED A LOSS ON YOUR APPLIED THERAPEUTICS INVESTMENTS, CLICK HERE BEFORE FEBRUARY 18, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
- 01/30/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/30/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESS Newswire / January 30, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126062&wire=1 or contact Joseph E. Levi, Esq.
- 01/30/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/30/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 30, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=126005&wire=1 or contact Joseph E. Levi, Esq.
- 01/30/2025
|
APLT COURT NEWS: Applied Therapeutics has been Sued for Fraud - Contact BFA Law before February 18 Class Action Deadline if You Suffered Losses
- NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/30/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / January 30, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125983&wire=1 or contact Joseph E. Levi, Esq.
- 01/30/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/30/2025
|
The Gross Law Firm Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK , Jan. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 01/30/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK CITY, NY / ACCESS Newswire / January 30, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125960&wire=1 or contact Joseph E. Levi, Esq.
- 01/30/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125903&wire=1 or contact Joseph E. Levi, Esq.
- 01/29/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
- 01/29/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125885&wire=1 or contact Joseph E. Levi, Esq.
- 01/29/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc.(APLT)
- NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125869&wire=1 or contact Joseph E. Levi, Esq.
- 01/29/2025
|
APLT Deadline Approaching on February 18, 2025: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Class Action Lawsuit Deadline
- RADNOR, Pa. , Jan. 29, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period").
- 01/29/2025
|
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) should contact The Gross Law Firm about pending Class Action - APLT
- NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT).
- 01/29/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125858&wire=1 or contact Joseph E. Levi, Esq.
- 01/29/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125828&wire=1 or contact Joseph E. Levi, Esq.
- 01/29/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 29, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/29/2025
|
Lost Money on Applied Therapeutics, Inc. (APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125806&wire=1 or contact Joseph E. Levi, Esq.
- 01/29/2025
|
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Applied Therapeutics To Contact Him Directly To Discuss Their Options
- 01/29/2025
|
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125734&wire=1 or contact Joseph E. Levi, Esq.
- 01/29/2025
|
APLT COURT ALERT: The Applied Therapeutics Class Action Deadline is Approaching – Contact BFA Law before February 18 (NASDAQ:APLT)
- NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/29/2025
|
Investors who lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125704&wire=1 or contact Joseph E. Levi, Esq.
- 01/29/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/29/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125690&wire=1 or contact Joseph E. Levi, Esq.
- 01/29/2025
|
APLT INVESTOR NOTICE: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
- SAN DIEGO , Jan. 29, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, all dates inclusive (the "Class Period"), have until Tuesday, February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v.
- 01/29/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125686&wire=1 or contact Joseph E. Levi, Esq.
- 01/29/2025
|
APLT Lead Plaintiff Deadline Approaching - Contact Robbins LLP for Information About the Pending Class Action Against Applied Therapeutics, Inc.
- SAN DIEGO , Jan. 29, 2025 /PRNewswire/ -- Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024. Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases.
- 01/29/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / January 28, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125603&wire=1 or contact Joseph E. Levi, Esq.
- 01/28/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 28, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125591&wire=1 or contact Joseph E. Levi, Esq.
- 01/28/2025
|
APLT COURT NOTICE: BFA Law Alerts Applied Therapeutics Investors of the February 18 Class Action Deadline - Contact the Firm if You Lost Money
- NEW YORK, NY / ACCESS Newswire / January 28, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/28/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK CITY, NY / ACCESS Newswire / January 28, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125564&wire=1 or contact Joseph E. Levi, Esq.
- 01/28/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK , Jan. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/28/2025
|
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- BENSALEM, Pa. , Jan. 28, 2025 /PRNewswire/ -- The Law Offices of Howard G.
- 01/28/2025
|
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Jan. 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ: APLT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/28/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 28, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125502&wire=1 or contact Joseph E. Levi, Esq.
- 01/28/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Applied Therapeutics, Inc. to Contact the Firm Today!
- NEW YORK CITY, NY / ACCESS Newswire / January 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/28/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK , Jan. 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 01/28/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125413&wire=1 or contact Joseph E. Levi, Esq.
- 01/27/2025
|
Lead Plaintiff Deadline Approaching in APLT: Kessler Topaz Meltzer & Check, LLP Reminds Investors A Securities Fraud Class Action Has Been Filed Against Applied Therapeutics, Inc. (APLT)
- RADNOR, Pa., Jan. 27, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.
- 01/27/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125408&wire=1 or contact Joseph E. Levi, Esq.
- 01/27/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125394&wire=1 or contact Joseph E. Levi, Esq.
- 01/27/2025
|
ROSEN, LEADING INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 01/27/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.
- 01/27/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125372&wire=1 or contact Joseph E. Levi, Esq.
- 01/27/2025
|
Lost Money on Applied Therapeutics, Inc. (APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125339&wire=1 or contact Joseph E. Levi, Esq.
- 01/27/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/27/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125282&wire=1 or contact Joseph E. Levi, Esq.
- 01/27/2025
|
APLT SHAREHOLDER NEWS: Applied Therapeutics Investors are Alerted of Pending Class Action - Contact BFA Law before Expiration of February 18 Deadline (NASDAQ:APLT)
- NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/27/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125267&wire=1 or contact Joseph E. Levi, Esq.
- 01/27/2025
|
APLT Stockholders Have Opportunity to Lead Applied Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/27/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK , Jan. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 01/27/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESS Newswire / January 26, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125168&wire=1 or contact Joseph E. Levi, Esq.
- 01/26/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/26/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/26/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / January 26, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125141&wire=1 or contact Joseph E. Levi, Esq.
- 01/26/2025
|
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit
- NEW YORK , Jan. 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. So what: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/26/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 26, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125129&wire=1 or contact Joseph E. Levi, Esq.
- 01/26/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / January 26, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125100&wire=1 or contact Joseph E. Levi, Esq.
- 01/26/2025
|
APLT Shareholders Have Opportunity to Lead Applied Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/26/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / January 25, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125084&wire=1 or contact Joseph E. Levi, Esq.
- 01/25/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/25/2025
|
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / January 25, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/25/2025
|
APLT SHAREHOLDER REPORT: A Class Action was filed on behalf of Applied Therapeutics Investors – Contact BFA Law before February 18 Legal Deadline (NASDAQ:APLT)
- NEW YORK, Jan. 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/25/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=125020&wire=1 or contact Joseph E. Levi, Esq.
- 01/24/2025
|
APLT CLASS ACTION ALERT: Applied Therapeutics has been Sued for Fraud after Stock Declines 80% - Contact BFA Law by February 18 if You Suffered Losses
- NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/24/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124959&wire=1 or contact Joseph E. Levi, Esq.
- 01/24/2025
|
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 01/24/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/24/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / January 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/24/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - APLT
- NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124917&wire=1 or contact Joseph E. Levi, Esq.
- 01/24/2025
|
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Applied Therapeutics To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / January 24, 2025 / If you purchased or acquired securities in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT) and reminds investors of the February 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 01/24/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124835&wire=1 or contact Joseph E. Levi, Esq.
- 01/24/2025
|
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESS Newswire / January 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/24/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK , Jan. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 01/24/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124780&wire=1 or contact Joseph E. Levi, Esq.
- 01/24/2025
|
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / January 23, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/23/2025
|
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Applied Therapeutics, Inc.
- RADNOR, Pa. , Jan. 23, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period").
- 01/23/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
- 01/23/2025
|
APLT CLASS ACTION UPDATE: Applied Therapeutics Investors are Notified of Imminent February 18 Court Deadline - Contact BFA Law if You Suffered Losses
- NEW YORK, NY / ACCESS Newswire / January 23, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/23/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK CITY, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124684&wire=1 or contact Joseph E. Levi, Esq.
- 01/23/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124652&wire=1 or contact Joseph E. Levi, Esq.
- 01/23/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 23, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/23/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124645&wire=1 or contact Joseph E. Levi, Esq.
- 01/23/2025
|
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Jan. 23, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ: APLT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/23/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124582&wire=1 or contact Joseph E. Levi, Esq.
- 01/23/2025
|
APLT CLASS ACTION DEADLINE: Applied Therapeutics, Inc. Investors are Reminded of the Pending Lawsuit – Contact BFA Law before February 18 Court Deadline (NASDAQ:APLT)
- NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/23/2025
|
Lost Money on Applied Therapeutics, Inc. (APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK CITY, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124578&wire=1 or contact Joseph E. Levi, Esq.
- 01/23/2025
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESS Newswire / January 23, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/23/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact The Gross Law Firm
- NEW YORK , Jan. 23, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 01/23/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124512&wire=1 or contact Joseph E. Levi, Esq.
- 01/22/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 – APLT
- NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124463&wire=1 or contact Joseph E. Levi, Esq.
- 01/22/2025
|
APLT CLASS ACTION NOTICE: Lose Money on Your Applied Therapeutics Investment? You may have been affected by Fraud - Contact BFA Law
- NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/22/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124454&wire=1 or contact Joseph E. Levi, Esq.
- 01/22/2025
|
ROSEN, LEADING INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / January 22, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/22/2025
|
Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124434&wire=1 or contact Joseph E. Levi, Esq.
- 01/22/2025
|
Investors who lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.
- 01/22/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124411&wire=1 or contact Joseph E. Levi, Esq.
- 01/22/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124384&wire=1 or contact Joseph E. Levi, Esq.
- 01/22/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124366&wire=1 or contact Joseph E. Levi, Esq.
- 01/22/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/22/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESSWIRE / January 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/22/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124325&wire=1 or contact Joseph E. Levi, Esq.
- 01/22/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124295&wire=1 or contact Joseph E. Levi, Esq.
- 01/22/2025
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/22/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124264&wire=1 or contact Joseph E. Levi, Esq.
- 01/21/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124260&wire=1 or contact Joseph E. Levi, Esq.
- 01/21/2025
|
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit
- NEW YORK , Jan. 21, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. So what: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/21/2025
|
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 01/21/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, NY / ACCESSWIRE / January 21, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124242&wire=1 or contact Joseph E. Levi, Esq.
- 01/21/2025
|
APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
- SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”), have until Tuesday, February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v. Applied Therapeutics, Inc., No. 24-cv-09715 (S.D.N.Y.), the Applied Therapeutics class action lawsuit charges Applied Therapeutics as well as certain of Applied Therapeutics' top executives with violations of the Securities Exchange Act of 1934.
- 01/21/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc.(APLT)
- NEW YORK, NY / ACCESSWIRE / January 21, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124231&wire=1 or contact Joseph E. Levi, Esq.
- 01/21/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK , Jan. 21, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/21/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESSWIRE / January 21, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124211&wire=1 or contact Joseph E. Levi, Esq.
- 01/21/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESSWIRE / January 21, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124173&wire=1 or contact Joseph E. Levi, Esq.
- 01/21/2025
|
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.
- 01/21/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124124&wire=1 or contact Joseph E. Levi, Esq.
- 01/21/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join – Contact The Gross Law Firm
- NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT).
- 01/21/2025
|
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , Jan. 21, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) have opportunity to lead the securities fraud class action lawsuit.
- 01/21/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/21/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124101&wire=1 or contact Joseph E. Levi, Esq.
- 01/21/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124045&wire=1 or contact Joseph E. Levi, Esq.
- 01/21/2025
|
APLT DEADLINE NOTICE: Applied Therapeutics Investors are Reminded of February 18 Class Action Deadline – Contact BFA Law if You Lost Money (NASDAQ:APLT)
- NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/21/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124019&wire=1 or contact Joseph E. Levi, Esq.
- 01/21/2025
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/21/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / January 20, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124001&wire=1 or contact Joseph E. Levi, Esq.
- 01/20/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123966&wire=1 or contact Joseph E. Levi, Esq.
- 01/20/2025
|
APLT DEADLINE: The February 18 Applied Therapeutics, Inc. Class Action Deadline is Approaching - Contact BFA Law if You Suffered Losses
- NEW YORK, NY / ACCESS Newswire / January 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/20/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123929&wire=1 or contact Joseph E. Levi, Esq.
- 01/20/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/20/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123818&wire=1 or contact Joseph E. Levi, Esq.
- 01/20/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123781&wire=1 or contact Joseph E. Levi, Esq.
- 01/20/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/20/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
- NEW YORK , Jan. 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 01/20/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / January 19, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123753&wire=1 or contact Joseph E. Levi, Esq.
- 01/19/2025
|
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / January 19, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/19/2025
|
APLT Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against Applied Therapeutics, Inc. (APLT)
- RADNOR, PA / ACCESS Newswire / January 19, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ:APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period"). The lead plaintiff deadline is February 18, 2025.
- 01/19/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / January 19, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123691&wire=1 or contact Joseph E. Levi, Esq.
- 01/19/2025
|
APLT FRAUD NEWS: A Class Action has been Filed Against Applied Therapeutics, Inc. for Securities Fraud – Contact BFA Law by February 18 Court Deadline (NASDAQ:APLT)
- NEW YORK, Jan. 19, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/19/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / January 19, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123669&wire=1 or contact Joseph E. Levi, Esq.
- 01/19/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 19, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/19/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 19, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123660&wire=1 or contact Joseph E. Levi, Esq.
- 01/19/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESSWIRE / January 19, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123627&wire=1 or contact Joseph E. Levi, Esq.
- 01/19/2025
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESS Newswire / January 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/19/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information – APLT
- NEW YORK, NY / ACCESSWIRE / January 18, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123616&wire=1 or contact Joseph E. Levi, Esq.
- 01/18/2025
|
ROSEN, A HIGHLY RECOGNIZED FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Jan. 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 01/18/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / January 18, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123610&wire=1 or contact Joseph E. Levi, Esq.
- 01/18/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESSWIRE / January 18, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123597&wire=1 or contact Joseph E. Levi, Esq.
- 01/18/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – APLT
- NEW YORK CITY, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/18/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / January 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/18/2025
|
Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky about Pending Class Action - APLT
- NEW YORK, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123560&wire=1 or contact Joseph E. Levi, Esq.
- 01/17/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit – APLT
- NEW YORK, NY / ACCESSWIRE / January 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123558&wire=1 or contact Joseph E. Levi, Esq.
- 01/17/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123535&wire=1 or contact Joseph E. Levi, Esq.
- 01/17/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
- 01/17/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123528&wire=1 or contact Joseph E. Levi, Esq.
- 01/17/2025
|
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK CITY, NY / ACCESS Newswire / January 17, 2025 / WHY: New York, N.Y., January 17, 2025.
- 01/17/2025
|
APLT FRAUD ALERT: Applied Therapeutics Sued after Stock Drops 80% - Investors with Losses are Urged to Contact BFA Law before February 18 Class Action Deadline
- NEW YORK CITY, NY / ACCESS Newswire / January 17, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/17/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK CITY, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123499&wire=1 or contact Joseph E. Levi, Esq.
- 01/17/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123479&wire=1 or contact Joseph E. Levi, Esq.
- 01/17/2025
|
Faruqi & Faruqi Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Applied Therapeutics To Contact Him Directly To Discuss Their Options
- 01/17/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123435&wire=1 or contact Joseph E. Levi, Esq.
- 01/17/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 17, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/17/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123394&wire=1 or contact Joseph E. Levi, Esq.
- 01/17/2025
|
APLT COURT NOTICE: Applied Therapeutics Investors are Notified of the February 18 Class Action Deadline – Contact BFA Law if You Lost Money (NASDAQ:APLT)
- NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/17/2025
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESS Newswire / January 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/17/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc.(APLT)
- NEW YORK , Jan. 17, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 01/17/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESS Newswire / January 16, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123340&wire=1 or contact Joseph E. Levi, Esq.
- 01/16/2025
|
APLT COURT NEWS: Applied Therapeutics, Inc. Sued for Securities Fraud - Investors that Lost Money are Urged to Contact BFA Law before February 18 Deadline
- NEW YORK CITY, NY / ACCESS Newswire / January 16, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/16/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESS Newswire / January 16, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/16/2025
|
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , Jan. 16, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). IF YOU SUFFERED A LOSS ON YOUR APPLIED THERAPEUTICS INVESTMENTS, CLICK HERE BEFORE FEBRUARY 18, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
- 01/16/2025
|
Investors Who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 16, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123317&wire=1 or contact Joseph E. Levi, Esq.
- 01/16/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESS Newswire / January 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/16/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / January 16, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123274&wire=1 or contact Joseph E. Levi, Esq.
- 01/16/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESS Newswire / January 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/16/2025
|
The Gross Law Firm Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK , Jan. 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 01/16/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - APLT
- NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123218&wire=1 or contact Joseph E. Levi, Esq.
- 01/15/2025
|
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.
- 01/15/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123195&wire=1 or contact Joseph E. Levi, Esq.
- 01/15/2025
|
APLT COURT REMINDER: The February 18 Deadline in the Applied Therapeutics Class Action is Approaching – Investors are Reminded to Contact BFA Law
- NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/15/2025
|
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 01/15/2025
|
Investors who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123185&wire=1 or contact Joseph E. Levi, Esq.
- 01/15/2025
|
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/15/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT).
- 01/15/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123131&wire=1 or contact Joseph E. Levi, Esq.
- 01/15/2025
|
Applied Therapeutics Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 15, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/15/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123030&wire=1 or contact Joseph E. Levi, Esq.
- 01/15/2025
|
APLT SHAREHOLDER ALERT: BFA Law Reminds Applied Therapeutics, Inc. Investors with Losses to Contact the Firm before February 18 Class Action Deadline (NASDAQ:APLT)
- NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/15/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=123020&wire=1 or contact Joseph E. Levi, Esq.
- 01/15/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / January 15, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/15/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Shareholders
- NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122983&wire=1 or contact Joseph E. Levi, Esq.
- 01/15/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / January 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122964&wire=1 or contact Joseph E. Levi, Esq.
- 01/14/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESSWIRE / January 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122931&wire=1 or contact Joseph E. Levi, Esq.
- 01/14/2025
|
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK CITY, NY / ACCESSWIRE / January 14, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/14/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / January 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122915&wire=1 or contact Joseph E. Levi, Esq.
- 01/14/2025
|
Applied Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 18, 2025 Deadline to file Lead Plaintiff Motion
- Investors can contact the law firm at no cost to learn more about recovering their losses
- 01/14/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122872&wire=1 or contact Joseph E. Levi, Esq.
- 01/14/2025
|
APLT SHAREHOLDER NEWS: BFA Law Announces that Applied Therapeutics, Inc. has been Sued for Fraud - Contact the Firm if You Suffered Losses
- NEW YORK, NY / ACCESSWIRE / January 14, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/14/2025
|
Investors Who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122851&wire=1 or contact Joseph E. Levi, Esq.
- 01/14/2025
|
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- BENSALEM, Pa. , Jan. 14, 2025 /PRNewswire/ -- The Law Offices of Howard G.
- 01/14/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / January 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122812&wire=1 or contact Joseph E. Levi, Esq.
- 01/14/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Shareholders
- NEW YORK, NY / ACCESSWIRE / January 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122797&wire=1 or contact Joseph E. Levi, Esq.
- 01/14/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESSWIRE / January 14, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/14/2025
|
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / January 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122762&wire=1 or contact Joseph E. Levi, Esq.
- 01/14/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122742&wire=1 or contact Joseph E. Levi, Esq.
- 01/14/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / January 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/14/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK , Jan. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 01/14/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / January 14, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122719&wire=1 or contact Joseph E. Levi, Esq.
- 01/14/2025
|
APLT INVESTOR NOTICE: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
- SAN DIEGO , Jan. 14, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), have until Tuesday, February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v.
- 01/14/2025
|
Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky about Pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122714&wire=1 or contact Joseph E. Levi, Esq.
- 01/13/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122656&wire=1 or contact Joseph E. Levi, Esq.
- 01/13/2025
|
ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK CITY, NY / ACCESSWIRE / January 13, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/13/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122622&wire=1 or contact Joseph E. Levi, Esq.
- 01/13/2025
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122604&wire=1 or contact Joseph E. Levi, Esq.
- 01/13/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122586&wire=1 or contact Joseph E. Levi, Esq.
- 01/13/2025
|
Investors who lost money on Applied Therapeutics, Inc. (APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.
- 01/13/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122534&wire=1 or contact Joseph E. Levi, Esq.
- 01/13/2025
|
Applied Therapeutics Inc Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/13/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122489&wire=1 or contact Joseph E. Levi, Esq.
- 01/13/2025
|
APLT CLASS ACTION NEWS: Applied Therapeutics, Inc. Investors are Notified of Upcoming February 18 Court Deadline – Contact BFA Law if You Suffered Losses (NASDAQ:APLT)
- NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/13/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122461&wire=1 or contact Joseph E. Levi, Esq.
- 01/13/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / January 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/13/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK , Jan. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 01/13/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122432&wire=1 or contact Joseph E. Levi, Esq.
- 01/13/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / January 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122397&wire=1 or contact Joseph E. Levi, Esq.
- 01/12/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
- 01/12/2025
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122382&wire=1 or contact Joseph E. Levi, Esq.
- 01/12/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESSWIRE / January 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/12/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESSWIRE / January 12, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/12/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / January 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122322&wire=1 or contact Joseph E. Levi, Esq.
- 01/12/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
- NEW YORK, NY / ACCESSWIRE / January 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122308&wire=1 or contact Joseph E. Levi, Esq.
- 01/12/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 12, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122261&wire=1 or contact Joseph E. Levi, Esq.
- 01/12/2025
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / January 12, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/12/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / January 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122241&wire=1 or contact Joseph E. Levi, Esq.
- 01/11/2025
|
Class Action Reminder for APLT Investors: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Securities Fraud Class Action Lawsuit
- RADNOR, Pa. , Jan. 11, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period").
- 01/11/2025
|
APLT INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO, Jan. 11, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), have until Tuesday, February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v. Applied Therapeutics, Inc., No. 24-cv-09715 (S.D.N.Y.), the Applied Therapeutics class action lawsuit charges Applied Therapeutics as well as certain of Applied Therapeutics' top executives with violations of the Securities Exchange Act of 1934.
- 01/11/2025
|
APLT CLASS ACTION ALERT: Applied Therapeutics Investors that Lost Money may have been Affected by Fraud – Contact BFA Law by February 18 Legal Deadline (NASDAQ:APLT)
- NEW YORK, Jan. 11, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/11/2025
|
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit
- NEW YORK , Jan. 11, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. So what: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/11/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122193&wire=1 or contact Joseph E. Levi, Esq.
- 01/10/2025
|
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/10/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – APLT
- NEW YORK, NY / ACCESSWIRE / January 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122183&wire=1 or contact Joseph E. Levi, Esq.
- 01/10/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, NY / ACCESSWIRE / January 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122150&wire=1 or contact Joseph E. Levi, Esq.
- 01/10/2025
|
APLT CLASS ACTION NOTICE: Lose Money on Your Applied Therapeutics Investment? Contact BFA Law about the Pending Class Action before Expiration of Court Deadline
- NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/10/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESSWIRE / January 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122117&wire=1 or contact Joseph E. Levi, Esq.
- 01/10/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/10/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / January 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122080&wire=1 or contact Joseph E. Levi, Esq.
- 01/10/2025
|
Applied Therapeutics Inc Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/10/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / January 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=122040&wire=1 or contact Joseph E. Levi, Esq.
- 01/10/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / January 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121960&wire=1 or contact Joseph E. Levi, Esq.
- 01/10/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / January 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121936&wire=1 or contact Joseph E. Levi, Esq.
- 01/10/2025
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / January 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/10/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK , Jan. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 01/10/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / January 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121893&wire=1 or contact Joseph E. Levi, Esq.
- 01/09/2025
|
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 01/09/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121837&wire=1 or contact Joseph E. Levi, Esq.
- 01/09/2025
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / January 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121793&wire=1 or contact Joseph E. Levi, Esq.
- 01/09/2025
|
APLT LEGAL ALERT: Applied Therapeutics, Inc. Investors are Encouraged to Contact BFA Law about the Ongoing Securities Fraud Class Action by February 18 Deadline
- NEW YORK, NY / ACCESSWIRE / January 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/09/2025
|
APLT Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors that a Securities Fraud Class Action Lawsuit Has Been Filed
- RADNOR, Pa., Jan. 09, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.
- 01/09/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121764&wire=1 or contact Joseph E. Levi, Esq.
- 01/09/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESSWIRE / January 9, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/09/2025
|
Investors who lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121691&wire=1 or contact Joseph E. Levi, Esq.
- 01/09/2025
|
APLT LEGAL UPDATE: What does the Applied Therapeutics, Inc. Class Action Mean for You? Contact BFA Law by February 18 Court Deadline (NASDAQ:APLT)
- NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/09/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / January 9, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/09/2025
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
- NEW YORK , Jan. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 01/09/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, NY / ACCESSWIRE / January 8, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121609&wire=1 or contact Joseph E. Levi, Esq.
- 01/08/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / January 8, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121602&wire=1 or contact Joseph E. Levi, Esq.
- 01/08/2025
|
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK CITY, NY / ACCESSWIRE / January 8, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/08/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / January 8, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121587&wire=1 or contact Joseph E. Levi, Esq.
- 01/08/2025
|
APLT LEGAL DEADLINE: Why was Applied Therapeutics, Inc. Sued for Securities Fraud? Investors are Urged to Contact BFA Law before February 18 Court Deadline
- NEW YORK, NY / ACCESSWIRE / January 8, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/08/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.
- 01/08/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 8, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121550&wire=1 or contact Joseph E. Levi, Esq.
- 01/08/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK , Jan. 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/08/2025
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / January 8, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121522&wire=1 or contact Joseph E. Levi, Esq.
- 01/08/2025
|
Applied Therapeutics Inc Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 8, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/08/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 8, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121510&wire=1 or contact Joseph E. Levi, Esq.
- 01/08/2025
|
Faruqi & Faruqi Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Applied Therapeutics To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Jan. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) and reminds investors of the February 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 01/08/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 8, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121458&wire=1 or contact Joseph E. Levi, Esq.
- 01/08/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 8, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121425&wire=1 or contact Joseph E. Levi, Esq.
- 01/08/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / January 8, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/08/2025
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / January 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121384&wire=1 or contact Joseph E. Levi, Esq.
- 01/07/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121339&wire=1 or contact Joseph E. Levi, Esq.
- 01/07/2025
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Applied Therapeutics To Contact Him Directly To Discuss Their Options NEW YORK, NY / ACCESSWIRE / January 7, 2025 / If you suffered losses exceeding $50,000 in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT) and reminds investors of the February 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 01/07/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESSWIRE / January 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121298&wire=1 or contact Joseph E. Levi, Esq.
- 01/07/2025
|
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 7, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/07/2025
|
APLT INVESTOR REPORT: Applied Therapeutics, Inc. Sued after Stock Plummets 80% - Investors with Losses are Urged to Contact BFA Law before February 18 Legal Deadline
- NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/07/2025
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121273&wire=1 or contact Joseph E. Levi, Esq.
- 01/07/2025
|
Investors who lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class Action - APLT
- NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT).
- 01/07/2025
|
Shareholders That Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121249&wire=1 or contact Joseph E. Levi, Esq.
- 01/07/2025
|
Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit
- RADNOR, PA / ACCESSWIRE / January 7, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ:APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period"). The lead plaintiff deadline is February 18, 2025.
- 01/07/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121237&wire=1 or contact Joseph E. Levi, Esq.
- 01/07/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESSWIRE / January 7, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/07/2025
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121185&wire=1 or contact Joseph E. Levi, Esq.
- 01/07/2025
|
APLT INVESTOR NOTICE: Applied Therapeutics, Inc. Investors are Notified of Upcoming February 18 Class Action Deadline – Contact BFA Law if You Lost Money (NASDAQ:APLT)
- NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/07/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 7, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121159&wire=1 or contact Joseph E. Levi, Esq.
- 01/07/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Applied Therapeutics, Inc. to Contact the Firm Today!
- NEW YORK CITY, NY / ACCESSWIRE / January 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/07/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK , Jan. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 01/07/2025
|
Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121096&wire=1 or contact Joseph E. Levi, Esq.
- 01/06/2025
|
APLT Investor Alert: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Applied Therapeutics, Inc.
- SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024. Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases.
- 01/06/2025
|
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit
- NEW YORK , Jan. 6, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. So what: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/06/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – APLT
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121088&wire=1 or contact Joseph E. Levi, Esq.
- 01/06/2025
|
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 01/06/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121048&wire=1 or contact Joseph E. Levi, Esq.
- 01/06/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
- 01/06/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121026&wire=1 or contact Joseph E. Levi, Esq.
- 01/06/2025
|
APLT INVESTOR NEWS: Applied Therapeutics, Inc. has been Sued for Securities Fraud - Contact BFA Law if You Lost Money by February 18 Court Deadline
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/06/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Shareholders
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=121004&wire=1 or contact Joseph E. Levi, Esq.
- 01/06/2025
|
Applied Therapeutics Inc Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/06/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120984&wire=1 or contact Joseph E. Levi, Esq.
- 01/06/2025
|
Applied Therapeutics Inc Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/06/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120956&wire=1 or contact Joseph E. Levi, Esq.
- 01/06/2025
|
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Jan. 6, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ: APLT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/06/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/06/2025
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120840&wire=1 or contact Joseph E. Levi, Esq.
- 01/06/2025
|
Lost Money on Applied Therapeutics, Inc. (APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120835&wire=1 or contact Joseph E. Levi, Esq.
- 01/06/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Applied Therapeutics, Inc. to Contact the Firm Today!
- NEW YORK CITY, NY / ACCESSWIRE / January 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/06/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Shareholders
- NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120801&wire=1 or contact Joseph E. Levi, Esq.
- 01/06/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120793&wire=1 or contact Joseph E. Levi, Esq.
- 01/05/2025
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120789&wire=1 or contact Joseph E. Levi, Esq.
- 01/05/2025
|
APLT REMINDER: Kessler Topaz Meltzer & Check, LLP Urges APLT Investors with Losses to Contact the Firm
- RADNOR, Pa. , Jan. 5, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period").
- 01/05/2025
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120734&wire=1 or contact Joseph E. Levi, Esq.
- 01/05/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESSWIRE / January 5, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/05/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESSWIRE / January 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/05/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120698&wire=1 or contact Joseph E. Levi, Esq.
- 01/05/2025
|
APLT LAWSUIT DEADLINE: BFA Law Alerts Applied Therapeutics, Inc. Investors of Imminent February 18 Class Action Deadline – Contact the Firm if You Lost Money (NASDAQ:APLT)
- NEW YORK, Jan. 05, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/05/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc.(APLT)
- NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120674&wire=1 or contact Joseph E. Levi, Esq.
- 01/05/2025
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Applied Therapeutics, Inc. to Contact the Firm Today!
- NEW YORK CITY, NY / ACCESSWIRE / January 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/05/2025
|
Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / January 4, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120641&wire=1 or contact Joseph E. Levi, Esq.
- 01/04/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 4, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120624&wire=1 or contact Joseph E. Levi, Esq.
- 01/04/2025
|
Applied Therapeutics Inc Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 4, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/04/2025
|
APLT Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges APLT Investors with Losses to Contact the Firm
- RADNOR, Pa., Jan. 03, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.
- 01/03/2025
|
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 01/03/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
- NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120572&wire=1 or contact Joseph E. Levi, Esq.
- 01/03/2025
|
APLT LAWSUIT: A Class Action Lawsuit has been Filed against Applied Therapeutics, Inc. - Contact BFA Law before Imminent February 18 Deadline
- NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/03/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120529&wire=1 or contact Joseph E. Levi, Esq.
- 01/03/2025
|
Deadline Approaching: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming February 18, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN APPLIED THERAPEUTICS, INC. (APLT), CONTACT THE LAW OFFICES OF HOWARD.
- 01/03/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK CITY, NY / ACCESSWIRE / January 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/03/2025
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120482&wire=1 or contact Joseph E. Levi, Esq.
- 01/03/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics Inc
- LOS ANGELES, CA / ACCESSWIRE / January 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/03/2025
|
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120415&wire=1 or contact Joseph E. Levi, Esq.
- 01/03/2025
|
Applied Therapeutics, Inc. Class Action: Investors are Alerted the Company has been Sued for Fraud – Contact BFA Law by the February 18 Court Deadline (NASDAQ:APLT)
- NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/03/2025
|
APLT Stockholders Have Opportunity to Lead Applied Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESSWIRE / January 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/03/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK , Jan. 3, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 01/03/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120383&wire=1 or contact Joseph E. Levi, Esq.
- 01/03/2025
|
APLT STOCK NEWS: Lose Money when Applied Therapeutics, Inc. Stock Dropped 80%? Contact BFA Law before February 18 Class Action Deadline
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/02/2025
|
Robbins LLP Reminds Investors of the Applied Therapeutics, Inc. (APLT) Class Action and Urges Investors with Large Losses to Contact the Firm for Information
- SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024. Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases.
- 01/02/2025
|
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Investors
- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”). Applied Therapeutics investors have until February 18, 2025 to file a lead plaintiff motion. If.
- 01/02/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119992&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Encouraged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 01/02/2025
|
Investors in Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK , Jan. 2, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 01/02/2025
|
Investors who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120171&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120167&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - APLT
- LOS ANGELES , Jan. 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ: APLT) for violations of the federal securities laws. Shareholders who bought the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the DJS Law Group before February 18, 2025.
- 01/02/2025
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK , Jan. 2, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/02/2025
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120093&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120069&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESSWIRE / January 2, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/02/2025
|
APLT Shareholders Have Opportunity to Lead Applied Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESSWIRE / January 2, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 01/02/2025
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120054&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
APLT INVESTOR NOTICE: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO , Jan. 2, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), have until Tuesday, February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v.
- 01/02/2025
|
Lost Money on Applied Therapeutics, Inc. (APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119936&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119911&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119890&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119869&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119962&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / January 1, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=120024&wire=1 or contact Joseph E. Levi, Esq.
- 01/02/2025
|
APLT STOCK UPDATE: Applied Therapeutics, Inc. Investors are Notified of Upcoming Class Action Deadline; Contact BFA Law by February 18 (NASDAQ:APLT)
- NEW YORK, Jan. 01, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 01/01/2025
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 31, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119834&wire=1 or contact Joseph E. Levi, Esq.
- 12/31/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit – APLT
- NEW YORK, NY / ACCESSWIRE / December 31, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119816&wire=1 or contact Joseph E. Levi, Esq.
- 12/31/2024
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
- 12/31/2024
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESSWIRE / December 31, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119758&wire=1 or contact Joseph E. Levi, Esq.
- 12/31/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESSWIRE / December 31, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 12/31/2024
|
The Schall Law Firm Urges Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics Inc
- LOS ANGELES, CA / ACCESSWIRE / December 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/31/2024
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 31, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119747&wire=1 or contact Joseph E. Levi, Esq.
- 12/31/2024
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 31, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119733&wire=1 or contact Joseph E. Levi, Esq.
- 12/31/2024
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 31, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119645&wire=1 or contact Joseph E. Levi, Esq.
- 12/31/2024
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 31, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/31/2024
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK , Dec. 31, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 12/31/2024
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESSWIRE / December 30, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119600&wire=1 or contact Joseph E. Levi, Esq.
- 12/30/2024
|
ROSEN, A TOP-RANKED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Dec. 31, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 12/30/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit – APLT
- NEW YORK, NY / ACCESSWIRE / December 30, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119575&wire=1 or contact Joseph E. Levi, Esq.
- 12/30/2024
|
APLT Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Applied Therapeutics, Inc. (APLT)
- RADNOR, Pa. , Dec. 30, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. ("Applied Therapeutics") (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the "Class Period").
- 12/30/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / December 30, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119547&wire=1 or contact Joseph E. Levi, Esq.
- 12/30/2024
|
ROSEN, A TOP-RANKED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Dec. 30, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 12/30/2024
|
APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, all dates inclusive (the “Class Period”), have until February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v. Applied Therapeutics, Inc., No. 24-cv-09715 (S.D.N.Y.), the Applied Therapeutics class action lawsuit charges Applied Therapeutics as well as certain of Applied Therapeutics' top executives with violations of the Securities Exchange Act of 1934.
- 12/30/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / December 30, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119532&wire=1 or contact Joseph E. Levi, Esq.
- 12/30/2024
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK--(BUSINESS WIRE)---- $APLT #APLT--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise.
- 12/30/2024
|
APLT STOCK REPORT: Applied Therapeutics, Inc. was Sued for Fraud - Contact BFA Law before February 18 Class Action Deadline if You have Losses on Your Investment
- NEW YORK, NY / ACCESSWIRE / December 30, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 12/30/2024
|
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Investors
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”). Applied Therapeutics investors have until February 18, 2025 to file a lead plaintiff motion. Investors suffering losses on their Applied Therapeutics investments are encoura.
- 12/30/2024
|
Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / December 30, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119505&wire=1 or contact Joseph E. Levi, Esq.
- 12/30/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
- NEW YORK, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.
- 12/30/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESSWIRE / December 30, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 12/30/2024
|
Law Offices of Frank R. Cruz Encourages Applied Therapeutics, Inc. (APLT) Investors To Inquire About Securities Fraud Class Action
- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Encourages Applied Therapeutics, Inc. (APLT) Investors To Inquire About Securities Fraud Class Action.
- 12/30/2024
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 30, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119471&wire=1 or contact Joseph E. Levi, Esq.
- 12/30/2024
|
Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / December 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/30/2024
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 30, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119449&wire=1 or contact Joseph E. Levi, Esq.
- 12/30/2024
|
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Dec. 30, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ: APLT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/30/2024
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 30, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119378&wire=1 or contact Joseph E. Levi, Esq.
- 12/30/2024
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 29, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119326&wire=1 or contact Joseph E. Levi, Esq.
- 12/29/2024
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / December 29, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119312&wire=1 or contact Joseph E. Levi, Esq.
- 12/29/2024
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK , Dec. 29, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ: APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/29/2024
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 29, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119295&wire=1 or contact Joseph E. Levi, Esq.
- 12/29/2024
|
The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Applied Therapeutics Inc
- LOS ANGELES, CA / ACCESSWIRE / December 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/29/2024
|
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Lawsuit
- NEW YORK , Dec. 29, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. So what: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 12/29/2024
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
- NEW YORK, NY / ACCESSWIRE / December 29, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119255&wire=1 or contact Joseph E. Levi, Esq.
- 12/29/2024
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 29, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119248&wire=1 or contact Joseph E. Levi, Esq.
- 12/29/2024
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 29, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119224&wire=1 or contact Joseph E. Levi, Esq.
- 12/29/2024
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 29, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/29/2024
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 28, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119158&wire=1 or contact Joseph E. Levi, Esq.
- 12/28/2024
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESSWIRE / December 28, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119154&wire=1 or contact Joseph E. Levi, Esq.
- 12/28/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / December 28, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119134&wire=1 or contact Joseph E. Levi, Esq.
- 12/28/2024
|
Applied Therapeutics Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / December 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/28/2024
|
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Dec. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 12/28/2024
|
APPLIED CLASS ACTION LAWSUIT: Applied Therapeutics, Inc. Investors with Losses are Notified of February 18 Deadline in Securities Fraud Class Action – Contact BFA Law (NASDAQ:APLT)
- NEW YORK, Dec. 28, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 12/28/2024
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119099&wire=1 or contact Joseph E. Levi, Esq.
- 12/27/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK , Dec. 27, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 12/27/2024
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119076&wire=1 or contact Joseph E. Levi, Esq.
- 12/27/2024
|
APLT CLASS ACTION ALERT: Applied Therapeutics, Inc. Investors are Notified of the Ongoing Class Action Lawsuit - Contact BFA Law before February 18 Court Deadline
- NEW YORK, NY / ACCESSWIRE / December 27, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 12/27/2024
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119056&wire=1 or contact Joseph E. Levi, Esq.
- 12/27/2024
|
APLT Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT) - Contact Kessler Topaz Meltzer & Check, LLP
- RADNOR, Pa., Dec. 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.
- 12/27/2024
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119042&wire=1 or contact Joseph E. Levi, Esq.
- 12/27/2024
|
The Schall Law Firm Invites Shareholder Contributions To A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESSWIRE / December 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/27/2024
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=119019&wire=1 or contact Joseph E. Levi, Esq.
- 12/27/2024
|
APLT INVESTOR DEADLINE: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- SAN DIEGO , Dec. 27, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), have until February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v.
- 12/27/2024
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118924&wire=1 or contact Joseph E. Levi, Esq.
- 12/27/2024
|
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118909&wire=1 or contact Joseph E. Levi, Esq.
- 12/27/2024
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/27/2024
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK , Dec. 27, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 12/27/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / December 27, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118880&wire=1 or contact Joseph E. Levi, Esq.
- 12/27/2024
|
APPLIED THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. and Encourages Investors to Contact the Firm
- NEW YORK, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”). Investors have until February 18, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- 12/26/2024
|
Faruqi & Faruqi Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 – APLT
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Applied Therapeutics To Contact Him Directly To Discuss Their Options
- 12/26/2024
|
APLT DEADLINE NOTICE: A Class Action was filed on behalf of Applied Therapeutics, Inc. Shareholders - Contact BFA Law if You Lost Money before Court Deadline (APLT)
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 12/26/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 12/26/2024
|
Applied Therapeutics Inc Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / December 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/26/2024
|
Investors who lost money on Applied Therapeutics, Inc. (APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118697&wire=1 or contact Joseph E. Levi, Esq.
- 12/26/2024
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118669&wire=1 or contact Joseph E. Levi, Esq.
- 12/26/2024
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118645&wire=1 or contact Joseph E. Levi, Esq.
- 12/26/2024
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118621&wire=1 or contact Joseph E. Levi, Esq.
- 12/26/2024
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118599&wire=1 or contact Joseph E. Levi, Esq.
- 12/26/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118577&wire=1 or contact Joseph E. Levi, Esq.
- 12/26/2024
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118556&wire=1 or contact Joseph E. Levi, Esq.
- 12/26/2024
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118536&wire=1 or contact Joseph E. Levi, Esq.
- 12/26/2024
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118768&wire=1 or contact Joseph E. Levi, Esq.
- 12/26/2024
|
APPLIED DEADLINE NEWS: Applied Therapeutics, Inc. was Sued for Securities Fraud – Contact BFA Law before February 18 Class Action Deadline (NASDAQ:APLT)
- NEW YORK, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 12/26/2024
|
Lost Money on Applied Therapeutics, Inc. (APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118751&wire=1 or contact Joseph E. Levi, Esq.
- 12/26/2024
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/26/2024
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/26/2024
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
- NEW YORK , Dec. 26, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 12/26/2024
|
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / December 26, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118725&wire=1 or contact Joseph E. Levi, Esq.
- 12/26/2024
|
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Dec. 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.
- 12/25/2024
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Dec. 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
- 12/25/2024
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118485&wire=1 or contact Joseph E. Levi, Esq.
- 12/24/2024
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT
- NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118475&wire=1 or contact Joseph E. Levi, Esq.
- 12/24/2024
|
Kirby McInerney LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Class Action Filing and Encourages Investors to Contact the Firm
- NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company.
- 12/24/2024
|
Investors Who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118451&wire=1 or contact Joseph E. Levi, Esq.
- 12/24/2024
|
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Lawsuit
- NEW YORK , Dec. 24, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
- 12/24/2024
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118434&wire=1 or contact Joseph E. Levi, Esq.
- 12/24/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK, NY / ACCESSWIRE / December 24, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 12/24/2024
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118408&wire=1 or contact Joseph E. Levi, Esq.
- 12/24/2024
|
The Schall Law Firm Encourages Shareholder Contributions To A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESSWIRE / December 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/24/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118374&wire=1 or contact Joseph E. Levi, Esq.
- 12/24/2024
|
APLT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In APLT To Contact Him Directly To Discuss Their Options
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Applied Therapeutics To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 24, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) and reminds investors of the February 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 12/24/2024
|
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - APLT
- NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118370&wire=1 or contact Joseph E. Levi, Esq.
- 12/24/2024
|
APPLIED FRAUD NOTICE: BFA Law Notifies Applied Therapeutics, Inc. Investors the Company was Sued for Fraud and Urges You to Contact the Firm (NASDAQ:APLT)
- NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 12/24/2024
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118364&wire=1 or contact Joseph E. Levi, Esq.
- 12/24/2024
|
APLT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 24, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/24/2024
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118325&wire=1 or contact Joseph E. Levi, Esq.
- 12/23/2024
|
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - APLT
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118323&wire=1 or contact Joseph E. Levi, Esq.
- 12/23/2024
|
Applied Therapeutics Inc. Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / December 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/23/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit – APLT
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118301&wire=1 or contact Joseph E. Levi, Esq.
- 12/23/2024
|
APLT Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Applied Therapeutics, Inc.
- RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025. CONTACT KESSLER TOPAZ MELTZER &.
- 12/23/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – APLT
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 12/23/2024
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118287&wire=1 or contact Joseph E. Levi, Esq.
- 12/23/2024
|
APLT Investor Alert: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Applied Therapeutics, Inc.
- SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024. Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases.
- 12/23/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118264&wire=1 or contact Joseph E. Levi, Esq.
- 12/23/2024
|
APLT FRAUD REPORT: Suffer Losses on Applied Therapeutics, Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law (APLT)
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 12/23/2024
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118189&wire=1 or contact Joseph E. Levi, Esq.
- 12/23/2024
|
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Dec. 23, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ: APLT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/23/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118138&wire=1 or contact Joseph E. Levi, Esq.
- 12/23/2024
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118110&wire=1 or contact Joseph E. Levi, Esq.
- 12/23/2024
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 23, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/23/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118091&wire=1 or contact Joseph E. Levi, Esq.
- 12/23/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
- NEW YORK , Dec. 23, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 12/23/2024
|
APLT INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), have until February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v. Applied Therapeutics, Inc., No. 24-cv-09715 (S.D.N.Y.), the Applied Therapeutics class action lawsuit charges Applied Therapeutics as well as certain of Applied Therapeutics' top executives with violations of the Securities Exchange Act of 1934.
- 12/23/2024
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 22, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118082&wire=1 or contact Joseph E. Levi, Esq.
- 12/22/2024
|
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Dec. 22, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 18, 2025.
- 12/22/2024
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 22, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118081&wire=1 or contact Joseph E. Levi, Esq.
- 12/22/2024
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 22, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118069&wire=1 or contact Joseph E. Levi, Esq.
- 12/22/2024
|
The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESSWIRE / December 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/22/2024
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK--(BUSINESS WIRE)---- $APLT #APLT--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise.
- 12/22/2024
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 22, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118009&wire=1 or contact Joseph E. Levi, Esq.
- 12/22/2024
|
APPLIED FRAUD ALERT: The Class Action Deadline for Applied Therapeutics, Inc. Investors is February 18 -- Contact BFA Law if You Lost Money (NASDAQ:APLT)
- NEW YORK, Dec. 22, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 12/22/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / December 22, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=118005&wire=1 or contact Joseph E. Levi, Esq.
- 12/22/2024
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 22, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/22/2024
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 21, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117957&wire=1 or contact Joseph E. Levi, Esq.
- 12/21/2024
|
Applied Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / December 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/21/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / December 21, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117939&wire=1 or contact Joseph E. Levi, Esq.
- 12/21/2024
|
Investors who lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / December 21, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117935&wire=1 or contact Joseph E. Levi, Esq.
- 12/21/2024
|
APLT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements re: Applied Therapeutics business & prospects, resulting in its stock trading at inflated prices.
- 12/21/2024
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Applied Therapeutics To Contact Him Directly To Discuss Their Options NEW YORK, NY / ACCESSWIRE / December 21, 2024 / If you suffered losses exceeding $50,000 in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT) and reminds investors of the February 17, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 12/21/2024
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, NY / ACCESSWIRE / December 20, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117905&wire=1 or contact Joseph E. Levi, Esq.
- 12/20/2024
|
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 20, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117900&wire=1 or contact Joseph E. Levi, Esq.
- 12/20/2024
|
The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Case Against Applied Therapeutics, Inc.
- LOS ANGELES, CA / ACCESSWIRE / December 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/20/2024
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 20, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117878&wire=1 or contact Joseph E. Levi, Esq.
- 12/20/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT
- NEW YORK , Dec. 20, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 12/20/2024
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK , Dec. 20, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ: APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/20/2024
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
- NEW YORK, NY / ACCESSWIRE / December 20, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117865&wire=1 or contact Joseph E. Levi, Esq.
- 12/20/2024
|
APLT COURT REMINDER: Applied Therapeutics, Inc. Investors that Lost Money when Stock Plummeted 80% are Encouraged to Contact BFA Law (NASDAQ:APLT)
- NEW YORK, NY / ACCESSWIRE / December 20, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 12/20/2024
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 20, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117818&wire=1 or contact Joseph E. Levi, Esq.
- 12/20/2024
|
APPLIED THERAPEUTICS BREAKING NEWS: BFA Law Announces that Applied Therapeutics, Inc. has been Sued for Securities Fraud – Investors with Losses Urged to Contact the Firm (NASDAQ:APLT)
- NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
- 12/20/2024
|
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 20, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117741&wire=1 or contact Joseph E. Levi, Esq.
- 12/20/2024
|
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 20, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/20/2024
|
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK , Dec. 20, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024.
- 12/20/2024
|
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 – APLT
- NEW YORK, NY / ACCESSWIRE / December 19, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117704&wire=1 or contact Joseph E. Levi, Esq.
- 12/19/2024
|
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Applied Therapeutics, Inc.
- SAN DIEGO , Dec. 19, 2024 /PRNewswire/ -- Robbins LLP announces that a class action was filed on behalf of all investors who purchased or otherwise acquired Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024. Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases.
- 12/19/2024
|
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 19, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117687&wire=1 or contact Joseph E. Levi, Esq.
- 12/19/2024
|
Applied Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / December 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/19/2024
|
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESSWIRE / December 19, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117673&wire=1 or contact Joseph E. Levi, Esq.
- 12/19/2024
|
ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - APLT
- NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 18, 2025.
- 12/19/2024
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 19, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117650&wire=1 or contact Joseph E. Levi, Esq.
- 12/19/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – APLT
- NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 12/19/2024
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join – Contact Levi & Korsinsky
- NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit.
- 12/19/2024
|
Lost Money on Applied Therapeutics, Inc. (APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 19, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117522&wire=1 or contact Joseph E. Levi, Esq.
- 12/19/2024
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 19, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/19/2024
|
APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements re:Applied Therapeutics business & prospects, resulting in its stock trading at inflated prices.
- 12/19/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class Action - APLT
- NEW YORK , Dec. 19, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 12/19/2024
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
- NEW YORK, NY / ACCESSWIRE / December 18, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117466&wire=1 or contact Joseph E. Levi, Esq.
- 12/18/2024
|
The Schall Law Firm Invites Shareholder Contributions To A Securities Fraud Case Against Applied Therapeutics Inc.
- LOS ANGELES, CA / ACCESSWIRE / December 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
- 12/18/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / December 18, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117434&wire=1 or contact Joseph E. Levi, Esq.
- 12/18/2024
|
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Lawsuit
- NEW YORK , Dec. 18, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
- 12/18/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESSWIRE / December 18, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117423&wire=1 or contact Joseph E. Levi, Esq.
- 12/18/2024
|
APLT INVESTOR ALERT: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- SAN DIEGO , Dec. 18, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), have until February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v.
- 12/18/2024
|
APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES--(BUSINESS WIRE)--APLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm.
- 12/18/2024
|
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESSWIRE / December 18, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117412&wire=1 or contact Joseph E. Levi, Esq.
- 12/18/2024
|
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT)
- NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”).
- 12/18/2024
|
Investors Who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / December 18, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117392&wire=1 or contact Joseph E. Levi, Esq.
- 12/18/2024
|
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.
- 12/18/2024
|
APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Applied Therapeutics Class Action Lawsuit
- SAN DIEGO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”), have until February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v. Applied Therapeutics, Inc., No. 24-cv-09715 (S.D.N.Y.), the Applied Therapeutics class action lawsuit charges Applied Therapeutics and certain of Applied Therapeutics' top executives with violations of the Securities Exchange Act of 1934.
- 12/18/2024
|
Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
- NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”). Applied Therapeutics is a clinical-stage biopharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is.
- 12/18/2024
|
Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - APLT
- NEW YORK, NY / ACCESSWIRE / December 18, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117350&wire=1 or contact Joseph E. Levi, Esq.
- 12/18/2024
|
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Applied Therapeutics, Inc. (APLT) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
- ATLANTA, Dec. 18, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT). The lawsuit alleges that Defendants made materially false or misleading statements and/or concealed material adverse facts concerning the true state of Applied Therapeutics' Phase III INSPIRE trial; notably, electronic data capture issues and a dosing error in the dose-escalation phase of the study.
- 12/18/2024
|
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
- NEW YORK, NY / ACCESSWIRE / December 18, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117335&wire=1 or contact Joseph E. Levi, Esq.
- 12/18/2024
|
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESSWIRE / December 18, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period").
- 12/18/2024
|
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 17, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117143&wire=1 or contact Joseph E. Levi, Esq.
- 12/17/2024
|
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Applied Therapeutics, Inc. Securities and Sets a Lead Plaintiff Deadline of February 18, 2025
- NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive . You are hereby notified that the class action lawsuit Adrian Alexandru v.
- 12/17/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
- NEW YORK, NY / ACCESSWIRE / December 17, 2024 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=117135&wire=1 or contact Joseph E. Levi, Esq.
- 12/17/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT
- NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 12/17/2024
|
Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Investors to Connect
- NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/17/2024
|
An Investigation Has Commenced on Behalf of Applied Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your APLT Losses
- NEW YORK, NY / ACCESSWIRE / December 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/16/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT
- NEW YORK, NY / ACCESSWIRE / December 16, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 12/16/2024
|
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about Securities Fraud Investigation - APLT
- NEW YORK, NY / ACCESSWIRE / December 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/16/2024
|
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation
- NEW YORK, NY / ACCESSWIRE / December 16, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/16/2024
|
Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - APLT
- NEW YORK, NY / ACCESSWIRE / December 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/15/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT
- NEW YORK, NY / ACCESSWIRE / December 15, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 12/15/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT
- NEW YORK, NY / ACCESSWIRE / December 15, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 12/15/2024
|
Levi & Korsinsky Announces an Investigation on Behalf of Applied Therapeutics, Inc. (APLT) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESSWIRE / December 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/15/2024
|
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Reach Out
- NEW YORK, NY / ACCESSWIRE / December 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/15/2024
|
Applied Therapeutics, Inc. (APLT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
- NEW YORK, NY / ACCESSWIRE / December 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/13/2024
|
Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Connect
- NEW YORK, NY / ACCESSWIRE / December 13, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/13/2024
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Applied Therapeutics, Inc. (APLT)
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/12/2024
|
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors
- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Applied Therapeutics investments or would like to inquire about potentially pursuing claims to recover your lo.
- 12/12/2024
|
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) investors concerning the Company's possible violations of federal securities laws. On November 27, 2024, Applied Therapeutics disclosed that it had received a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration (“FDA”) regarding the New Drug Application (“NDA”) for the Company's Classic.
- 12/12/2024
|
Applied Therapeutics, Inc. Being Investigated on Behalf of Applied Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details.
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/12/2024
|
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
- NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/12/2024
|
The Law Offices of Frank R. Cruz Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors
- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On November 27, 2024, Applied Therapeutics disclosed that it had received a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration (.
- 12/11/2024
|
Applied Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - APLT
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/11/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 12/11/2024
|
ATTENTION Applied Therapeutics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/11/2024
|
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Applied Therapeutics, Inc. (APLT) and Encourages Stockholders to Learn More About the Investigation
- NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/11/2024
|
Shareholder Rights Advocates at Levi & Korsinsky Investigate Applied Therapeutics, Inc. (APLT) Regarding Possible Securities Fraud Violations
- NEW YORK, NY / ACCESSWIRE / December 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/10/2024
|
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Investors to Inquire about Securities Investigation
- NEW YORK, NY / ACCESSWIRE / December 10, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/10/2024
|
Lost Money on Applied Therapeutics, Inc.(APLT)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
- NEW YORK, NY / ACCESSWIRE / December 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/10/2024
|
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
- NEW YORK CITY, NY / ACCESSWIRE / December 10, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/10/2024
|
ATTENTION APLT SHAREHOLDERS: Investors who lost money on Applied Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESSWIRE / December 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/09/2024
|
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Shareholders to Inquire about Securities Investigation
- NEW YORK CITY, NY / ACCESSWIRE / December 9, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/09/2024
|
Applied Therapeutics, Inc. (APLT) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
- NEW YORK, NY / ACCESSWIRE / December 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/08/2024
|
Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Investors to Connect
- NEW YORK CITY, NY / ACCESSWIRE / December 8, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/08/2024
|
ATTENTION Applied Therapeutics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
- NEW YORK, NY / ACCESSWIRE / December 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/06/2024
|
Wolf Popper LLP Announces Investigation on Behalf of Applied Therapeutics, Inc. Investors
- NEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. (“Applied Therapeutics”) common stock (NASDAQ: APLT). Applied Therapeutics is a clinical-stage biopharmaceutical company.
- 12/06/2024
|
Investors who lost money on Applied Therapeutics, Inc. should contact Levi & Korsinsky about an ongoing investigation - APLT
- NEW YORK, NY / ACCESSWIRE / December 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/06/2024
|
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation
- NEW YORK CITY, NY / ACCESSWIRE / December 6, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/06/2024
|
Applied Therapeutics, Inc. Being Investigated on Behalf of Applied Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/05/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 12/05/2024
|
An Investigation Has Commenced on Behalf of Applied Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your APLT Losses.
- NEW YORK, NY / ACCESSWIRE / December 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/05/2024
|
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Applied Therapeutics, Inc. (APLT) and Encourages Investors to Learn More About the Investigation
- NEW YORK CITY, NY / ACCESSWIRE / December 5, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/05/2024
|
APLT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Applied Therapeutics, Inc. Shareholders Who Lost Money
- NEW YORK, NY / ACCESSWIRE / December 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Applied Therapeutics, Inc. ("Applied Therapeutics, Inc.") (NASDAQ:APLT) concerning possible violations of federal securities laws. Applied Therapeutics issued a press release on November 27, 2024, announcing "that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 12/04/2024
|
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
- NEW YORK CITY, NY / ACCESSWIRE / December 4, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/04/2024
|
Applied Therapeutics says it received FDA's warning letter for genetic disease drug study
- Applied Therapeutics said on Monday it received a warning letter limited to a trial studying its genetic disease drug, after the U.S. health regulator declined to approve the treatment last week.
- 12/02/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT
- NEW YORK , Dec. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 12/02/2024
|
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
- NEW YORK CITY, NY / ACCESSWIRE / December 1, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 12/01/2024
|
Applied Therapeutics Stock Plummets 73%. The FDA Delivers This Crushing Blow.
- The pharma company's shares are getting crushed after regulators decline to green light a drug to treat a rare disease.
- 11/29/2024
|
Applied Therapeutics Stock Plummets After FDA Rejects Metabolic Disease Drug
- Applied Therapeutics (APLT) shares cratered Friday as the biopharmaceutical firm reported that the Food and Drug Administration (FDA) rejected its application for its experimental treatment for a rare metabolic disease known as Galactosemia.
- 11/29/2024
|
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Applied Therapeutics, Inc. (APLT) and Encourages Stockholders to Learn More About the Investigation
- NEW YORK CITY, NY / ACCESSWIRE / November 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 11/29/2024
|
Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application
- On Wednesday, Applied Therapeutics, Inc APLT received an FDA Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat for Classic Galactosemia.
- 11/29/2024
|
APLT Stock Plunges 77% After FDA Issues CRL for Galactosemia Drug NDA
- Applied Therapeutics stock plummets 77% after the FDA issues a CRL for the company's NDA seeking approval for govorestat to treat classic galactosemia.
- 11/28/2024
|
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Investors to Inquire about Securities Investigation
- NEW YORK CITY, NY / ACCESSWIRE / November 28, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/APLT.
- 11/28/2024
|
US FDA declines to approve Applied Therapeutics' genetic disease drug
- The U.S. Food and Drug Administration on Wednesday declined to approve Applied Therapeutics' drug to treat galactosemia, a rare genetic metabolic disease, the company said.
- 11/27/2024
|
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
- NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia.
- 11/27/2024
|
Applied Therapeutics (APLT) Upgraded to Buy: Here's What You Should Know
- Applied Therapeutics (APLT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 10/29/2024
|
Is Applied Therapeutics (APLT) Outperforming Other Medical Stocks This Year?
- Here is how Applied Therapeutics Inc. (APLT) and Axonics Modulation Technologies (AXNX) have performed compared to their sector so far this year.
- 10/29/2024
|
Are Medical Stocks Lagging Applied Therapeutics (APLT) This Year?
- Here is how Applied Therapeutics Inc. (APLT) and CareCloud, Inc. (CCLD) have performed compared to their sector so far this year.
- 10/10/2024
|
Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?
- Here is how Applied Therapeutics Inc. (APLT) and Cardinal Health (CAH) have performed compared to their sector so far this year.
- 09/24/2024
|
All You Need to Know About Applied Therapeutics (APLT) Rating Upgrade to Buy
- Applied Therapeutics (APLT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 09/23/2024
|
APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA
- Applied Therapeutics stock surges 69% as the FDA says that no advisory committee meeting is required to discuss the govorestat NDA for classic galactosemia.
- 09/19/2024
|
Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer
- Applied Therapeutics, Inc.'s stock surged nearly 70% yesterday after the news that the FDA will not hold an AdCom to discuss approval of AT-007 in galactosemia. AT-007 has shown clinical benefits in galactosemia and SORD deficiency, and its PDUFA for the former arrives at the end of November. With no AdCom, approval seems the likeliest outcome. Despite financial constraints, strong patient and HCP support suggest a successful commercial launch for govorestat, making Applied stock a “Buy” with expected valuation growth.
- 09/19/2024
|
Applied Therapeutics: FDA Stance Change For Advisory Panel Bodes Well For Review
- FDA removes the need for an advisory panel to first give a recommendation review of Applied Therapeutics, Inc.'s govorestat for the treatment of patients with galactosemia. PDUFA date of November 28th, 2024, remains on track for the FDA to decide whether govorestat should be approved to treat patients with galactosemia. Pre-NDA meeting with FDA expected in 2nd half of 2024 to discuss possible administrative actions of NDA filing submission of govorestat for the treatment of patients with SORD deficiency.
- 09/18/2024
|
Why Applied Therapeutics Stock Is Skyrocketing Today
- The FDA won't hold an Advisory Committee meeting to review Applied Therapeutics' regulatory filing for govorestat. This move could increase the likelihood that the drug will win FDA approval.
- 09/18/2024
|
Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside
- William Blair initiated coverage on Applied Therapeutics Inc. APLT, a late-stage development company focused on rare diseases such as galactosemia, SORD deficiency, and diabetic cardiomyopathy.
- 07/31/2024
|
Applied Therapeutics Added to Russell 3000® Index
- NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the Company was added to the Russell 3000® Index, effective after the U.S. market closed on June 28, 2024, as part of the 2024 Russell indexes annual reconstitution.
- 07/01/2024
|
Top 4 Health Care Stocks That May Keep You Up At Night This Month
- As of June 11, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
- 06/11/2024
|
Applied Therapeutics: A Strong Buy With AT-007 Nearing Approval For Galactosemia
- Applied Therapeutics is a clinical-stage biotech focused on treating symptoms of galactosemia in the central nervous system. Govorestat (AT-007) is in late-stage regulatory approval for galactosemia, with a PDUFA date set for November 2024. APLT holds $146.5 million in cash, ensuring a sufficient runway to FDA approval and initial product revenues by early 2025.
- 05/29/2024
|
Applied Therapeutics Reports First Quarter 2024 Financial Results
- NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the first quarter ended March 31, 2024.
- 05/09/2024
|
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
- NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the appointment of Dale Hooks as Chief Commercial Officer, replacing Adam Hansard, effective immediately. Mr. Hooks joins Applied with over 30 years of biopharmaceutical experience in rare disease marketing and sales, holding various leadership roles. Mr. Hooks will be responsible for leading Applied's commercial preparations for the potential launch of govorestat for the treatment of Classic Galactosemia and SORD.
- 04/15/2024
|
US FDA extends review of Applied Therapeutics' genetic disease drug
- The U.S. Food and Drug Administration has extended its review of Applied Therapeutics' experimental drug to treat galactosemia, a rare genetic metabolic disease, the company said on Thursday.
- 03/28/2024
|
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
- NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for govorestat (AT-007) for the treatment of Classic Galactosemia by three months. The FDA has set a new Prescription Drug User Fee Act (PDUFA) target action date of November 28, 2024.
- 03/28/2024
|
Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why
- Applied Therapeutics (APLT) surges 124% in a month due to encouraging updates from two separate developmental programs for govorestat to treat different rare neurological indications.
- 03/13/2024
|
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
- NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the fourth quarter and full year ended December 31, 2023.
- 03/06/2024
|
Why Is Applied Therapeutics (APLT) Stock Up 59% Today?
- Applied Therapeutics (NASDAQ: APLT ) stock is on the rise Wednesday after the clinical-stage biopharmaceutical company got an update from the Food and Drug Administration (FDA). The FDA has accepted the company's New Drug Application (NDA) for govorestat as a treatment for Classic Galactosemia.
- 02/28/2024
|
Applied Therapeutics Announces $100 Million Private Placement
- Financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors
- 02/28/2024
|
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
- PDUFA target action date of August 28, 2024 MAA validated and accepted for review by EMA in December 2023 NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) for govorestat (AT-007) for the treatment of Classic Galactosemia. The NDA was granted Priority Review status, and the FDA assigned a Prescription Drug User Free Act (PDUFA) target action date of August 28, 2024.
- 02/28/2024
|
Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible
- Positive 12-month interim results from the phase 3 INSPIRE study using govorestat for the treatment of patients with SORD deficiency achieved. Pre-NDA meeting with FDA to be sought out after to see if an NDA submission of govorestat for SORD deficiency could be done with only the positive 12-month interim data. 24-month interim results from the phase 3 INSPIRE study, using govorestat for the treatment of patients with SORD deficiency, is the next data readout to be expected.
- 02/16/2024
|
Applied Therapeutics stock falters on heart disease trial failure
- Applied Therapeutics shares plunged almost 35% after the biotechnology firm reported disappointing results from its Phase 3 heart disease trial. The company reported that its ARISE-HF trial of drug candidate AT-001 (caficrestat) in patients with diabetic cardiomyopathy (DbCM) at high risk of progressing to overt heart failure did not meet its primary endpoint of stabilization or improvement in cardiac functional capacity as measured by peak VO2.
- 01/05/2024
|
Why Is Applied Therapeutics (APLT) Stock Down 30% Today?
- Applied Therapeutics (NASDAQ: APLT ) stock is falling on Friday following the release of Phase 3 clinical trial data from the clinical-stage biopharmaceutical company. This data comes from Applied Therapeutics' ARISE-HF Phase 3 trial of AT-001 in patients with Diabetic Cardiomyopathy who have a high risk of overt heart failure.
- 01/05/2024
|
Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy
- AT-001 (caficrestat) demonstrated a strong trend in stabilizing cardiac functional capacity, while the placebo group declined over 15 months
- 01/04/2024
|
Applied Therapeutics: Multiple Inflection Points Could Generate Substantial Value
- EMA validated and accepted the regulatory application of govorestat for the treatment of patients with galactosemia; the FDA has a 60-day review period to look at the application for validation and acceptance. Release of results from the phase 3 ARISE-HF study, using AT-001 for the treatment of patients with cardiomyopathy, is expected any day now in Q1 of 2024. Release of results from the phase 3 INSPIRE study, using AT-007 for the treatment of patients with SORD Deficiency, expected Q1 of 2024.
- 01/04/2024
|
3 Penny Stocks To Buy According To Insiders In December
- Penny stocks – the cheap stocks trading under $5 per share, offer investors massive upside potential alongside higher risk. Since even incremental price moves translate into huge percentage gains in the stock market, timing entries right can set you up for explosive profits.
- 12/07/2023
|
Applied Therapeutics Reports Third Quarter 2023 Financial Results
- Regulatory submissions on track for govorestat (AT-007) for the treatment of Classic Galactosemia to US FDA and EMA in 4Q 2023
- 11/09/2023
|
Applied Therapeutics to Host Diabetic Cardiomyopathy Expert Forum with Key Opinion Leaders on Tuesday, November 7
- Forum to be Webcast Live Topline Phase 3 Data Readout from ARISE-HF Trial of AT-001 (caficrestat) in Diabetic Cardiomyopathy On Track for 4Q 2023 NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will host a Diabetic Cardiomyopathy (DbCM) expert forum with key opinion leaders on Tuesday, November 7, 2023 at 8:00 a.m. ET. Members of the Company's senior management team will be joined by the following key opinion leaders: James Januzzi, MD, Hutter Family Professor of Medicine, Harvard Medical School; Director, Dennis and Marilyn Barry Fellowship in Cardiology Research, Massachusetts General Hospital Gregory Lewis, MD, Director, Cardiopulmonary Exercise Testing Laboratory and Section Head, Heart Failure, Massachusetts General Hospital The agenda for the event is as follows: Diabetic Cardiomyopathy Disease Overview & Treatment Landscape (Dr. Januzzi) ARISE-HF Registrational Phase 3 Trial Overview (Dr. Januzzi) Cardiac Functional Capacity (primary endpoint in ARISE-HF) (Dr. Lewis) Q&A (with Drs.
- 11/01/2023
|
Applied Therapeutics to Present Baseline Data from Phase 3 ARISE-HF Study Evaluating AT-001 at the 2023 EASD Annual Meeting
- The ongoing ARISE-HF Phase 3 global clinical trial is evaluating the efficacy of AT-001 (caficrestat) on cardiac functional capacity in patients with diabetic cardiomyopathy (DbCM) Baseline data from ARISE-HF shows patients with DbCM exhibit reduced cardiac functional capacity resulting in decreased physical activity NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it will participate in a Symposium presentation, entitled Diabetic Cardiomyopathy (DbCM): a severe complication of diabetes, at the 59th European Association for the Study of Diabetes (EASD) Annual Meeting to take place October 2-6, 2023 in Hamburg, Germany and online.
- 09/28/2023
|
Applied Therapeutics Announces Successful Pre-NDA Meeting with the FDA and Confirms Plans to Submit NDA for Govorestat (AT-007) for Treatment of Classic Galactosemia to FDA in Q4 2023
- NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced successful completion of a recent pre-New Drug Application (“NDA”) meeting with the Food and Drug Administration (FDA) regarding its govorestat (AT-007) Galactosemia program. Based on discussions with the FDA, the Company believes they are aligned with the FDA and plans to submit an NDA for govorestat (AT-007) for the treatment of Galactosemia in the fourth quarter of this year.
- 09/06/2023
|
Applied Therapeutics: Buy For Upcoming Pre-NDA Meeting (I Expect A Positive Outcome)
- Applied Therapeutics is a micro-cap with low cash balance, but has major upcoming catalysts (pre-NDA meeting for galactosemia and phase 3 results in diabetic cardiomyopathy) and a huge upside potential. Despite missing the primary endpoint in galactosemia ph3 trial, APLT still plans for NDA submission. The pre-NDA meeting with the FDA this summer will be a big catalyst if positive. I expect a positive outcome from the meeting considering consistent and meaningful clinical benefit in multiple endpoints, orphan and fast-track designation, no alternative treatments, and the significant burden for affected patients.
- 08/17/2023
|
Applied Therapeutics to Present Baseline Data on the Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at the 2023 Annual Meeting of the American Diabetes Association
- NEW YORK, June 22, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced multiple presentations on AT-001 (caficrestat) and the ARISE-HF Phase 3 study in Diabetic Cardiomyopathy at the 2023 Annual Meeting of the American Diabetes Association to take place June 23 - 26 in San Diego, California.
- 06/22/2023
|
7 Hot Growth Stocks Poised to Triple in 2023
- Any investor seeking growth stocks that are poised to triple in 2023 will need a strong appetite for risk. That much is very clear.
- 05/05/2023
|
4 Top Penny Stocks To Buy According To Analysts, Targets Up To 695%
- Analysts say these could be penny stocks to buy. Do you agree with their outlook?
- 04/27/2023
|
3 Penny Stocks To Buy According To Analysts, Targets Up To 1,029%
- Analysts say these are penny stocks to buy but do you agree? The post 3 Penny Stocks To Buy According To Analysts, Targets Up To 1,029% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 04/25/2023
|
Applied Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
- NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will participate in a Neuromuscular & Bone Panel at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 2:10 p.m. ET in Boston.
- 03/01/2023
|
Applied Therapeutics to Present at the SVB Securities Global Biopharma Conference
- NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will present virtually at the SVB Securities Global Biopharma Conference on Thursday, February 16, 2023 at 2:20 p.m. ET.
- 02/09/2023
|
7 Top Penny Stocks To Watch With Big News This Week
- Hot penny stocks to watch with news this week. The post 7 Top Penny Stocks To Watch With Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 01/04/2023
|
10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022
- Penny stocks to buy according to analysts in 2022. The post 10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 10/19/2022
|
7 Penny Stocks To Buy According To Top Wall Street Analysts
- Penny stocks to buy according to analysts in 2022. The post 7 Penny Stocks To Buy According To Top Wall Street Analysts appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 10/18/2022
|
Best Penny Stocks To Buy Now? 3 With Heavy Insider Trading In October
- Best penny stocks to buy this week according to insiders. The post Best Penny Stocks To Buy Now?
- 10/14/2022
|
4 Hot Penny Stocks With News To Watch Right Now
- Hot penny stocks to watch. The post 4 Hot Penny Stocks With News To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 06/03/2022
|
Applied Therapeutics to Present at the UBS Global Healthcare Conference
- NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will participate in a fireside chat at the UBS Global Healthcare Conference on Wednesday, March 25, 2022 at 10:45 a.m. ET in New York.
- 05/19/2022
|
5 Biotech Stocks Set to Outpace Q1 Earnings Estimates
- Let us take a look at some drug/biotech stocks, ANGN, APLT, BOLT, IKNA and LABP, which are poised to beat on first-quarter earnings.
- 05/11/2022
|
Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited Metabolic Disorders
- NEW YORK, April 04, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced poster presentations at the 2022 43rd Annual Meeting of the Society for Inherited Metabolic Disorders, April 10 - 13, 2022 in Orlando, Florida.
- 04/04/2022
|
Bonds Are Screaming “Recession.” That's Great News For One Top Sector.
- The 10-2 year treasury yield spread is close to zero. Here's what you should do about this warning sign of a coming recession.
- 03/29/2022
|
Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics
- NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced their abstract #OP005 was accepted as an oral platform presentation at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics, March 22 – 26, 2022 in Nashville, Tennessee.
- 03/16/2022
|
Applied Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
- NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will present at the 11th Annual SVB Leerink Global Healthcare Conference on Friday, February 18, 2022 at 11:20 a.m. ET.
- 02/10/2022
|
Applied Therapeutics: Buying This Beaten-Down, Undervalued Rare Disease Company's Stock
- Applied Therapeutics shares were hammered this month after FDA did not agree to accelerated approval for its drug candidate AT-007 in treating galactosemia in children.
- 01/19/2022
|
Why Applied Therapeutics Stock Is Sliding Today
- The company's lead candidate, AT-007, is going to take a lot longer to reach patients than expected.
- 01/03/2022
|
Why Applied Therapeutics Shares Are Falling Today
- Applied Therapeutics (NASDAQ: APLT) is trading significantly lower Monday after the company said it would not immediately submit a new drug application for its AT-007 for treatment of galactosemia. The Galactosemia program had previously been discussed in the context of an NDA for accelerated approval based on reduction in galactitol, but the FDA has now indicated that clinical outcomes data will likely be required for approval.
- 01/03/2022
|
Applied Therapeutics To Hold Filing FDA Application For AT-007 In Rare Metabolic Disorder
- Following discussions with the FDA, Applied Therapeutics Inc (NASDAQ: APLT) has decided to hold on submitting a marketing application for AT-007 for Galactosemia pending additional talks with the agency. Although the Galactosemia program had previously been discussed for Accelerated Approval based on reduction in galactitol, the FDA has now indicated that clinical outcomes data will likely be required for approval.
- 01/03/2022
|
Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of Metabolism
- NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, has announced a symposium and poster presentations at the 14th International Congress of Inborn Errors of Metabolism (ICIEM), November 21-23, 2021, Sydney, Australia.
- 11/18/2021
|
Applied Therapeutics Reports Additional Pediatric Biomarker Data from ACTION-Galactosemia Kids
- Substantial and statistically significant reduction in plasma galactitol of 40% with new weight-based dosing parameters
- 10/18/2021
|
Applied Therapeutics Stock Drops On Delayed NDA Submission For Its Lead Candidate
- Applied Therapeutics Inc (NASDAQ: APLT) has reported initial biomarker data from the pediatric ACTION-Galactosemia Kids study and baseline analysis of the 47 children enrolled in the study. Related Content: FDA Fast Track Review For AT-007 In Rare Metabolic Disorder.
- 09/09/2021
|
Applied Therapeutics Reports Second Quarter 2021 Financial Results
- NDA submission for AT-007 in Galactosemia expected in Q3 2021; commercial preparations ongoing
- 08/12/2021
|
Applied Therapeutics Added to Russell Microcap® Index
- NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the Company has joined the Russell Microcap® Index. The newly reconstituted index took effect after the market close on Friday, June 25, 2021.
- 06/28/2021
|
Applied Therapeutics Announces Presentation of Data on the Prevalence of Diabetic Cardiomyopathy at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association
- ~1 in 5 people with diabetes or pre-diabetes have Diabetic Cardiomyopathy, a serious and progressive disease that limits the heart's ability to function People with diabetes or pre-diabetes who have Diabetic Cardiomyopathy are at high risk for developing overt heart failure
- 06/25/2021
|
Applied Therapeutics to Present on Diabetic Cardiomyopathy and Prevalence of Disease at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association
- NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced a Product Theater presentation at the upcoming 81st Scientific Sessions of the annual 2021 American Diabetes Association meeting taking place virtually June 25-29. The Product Theater will include an overview of Diabetic Cardiomyopathy (DbCM), the increased risk of progression to overt heart failure and death due to the disease, new data on the wide prevalence of the disease among patients with diabetes, the role of aldose reductase in the pathogenesis of disease, and a review of the ongoing ARISE-HF global registrational trial of AT-001, a novel and selective aldose reductase inhibitor.
- 06/21/2021
|
Applied Therapeutics Stock Moves Higher On FDA Fast Track Review For AT-007 In Rare Metabolic Disorder
- The FDA has granted Fast Track designation to Applied Therapeutics Inc's (NASDAQ: APLT) AT-007 to treat Galactosemia, a rare metabolic disease. AT-007 is the Company's central nervous system-penetrant Aldose Reductase inhibitor in development for multiple rare metabolic disorders.
- 06/17/2021
|
Applied Therapeutics Granted Fast Track Designation by FDA for AT-007 for Galactosemia
- NEW YORK, June 17, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AT-007 for the treatment of Galactosemia, a rare metabolic disease. AT-007 is the Company's central nervous system-penetrant Aldose Reductase inhibitor in development for multiple rare metabolic disorders, including Galactosemia, SORD and PMM2-CDG.
- 06/17/2021
|
Applied Therapeutics to Present at the UBS Global Healthcare Virtual Conference
- NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present at the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 at 10:00 a.m. ET.
- 05/19/2021
|
Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences
- NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present at two upcoming investor conferences in March:
- 02/23/2021
|
Applied Therapeutics, Inc. Announces Closing of Public Offering
- NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the closing of its public offering of 3,000,000 shares of its common stock, par value $0.0001 per share. The shares were offered at a price to the public of $23.00 per share, resulting in aggregate net proceeds of approximately $64.6 million, after deducting underwriting discounts and commissions and estimated offering expenses. The offering closed on February 17, 2021. The Company granted the underwriters a 30-day option to purchase up to 450,000 additional shares of its common stock at the price to the public, less underwriting discounts and commissions, which the underwriters exercised in full on February 17, 2021 and settled on February 19, 2021.
- 02/22/2021
|
Applied Therapeutics Raises $69M Via Equity
- Applied Therapeutics Inc (NASDAQ: APLT) prices its underwritten public offering of 3 million at $23 per share, raising $69 million in gross proceeds, at a marginal premium of 2%. Underwriters have an option to purchase up to 450,000 additional shares.
- 02/12/2021
|
Applied Therapeutics, Inc. Announces Pricing of Public Offering of 3,000,000 Shares of Common Stock
- NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the pricing of its underwritten public offering of 3,000,000 shares of its common stock, par value $0.0001 per share, at a price to the public of $23.00 per share. The gross proceeds to the Company from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company, are expected to be $69 million. The Company has granted the underwriters a 30-day option to purchase up to 450,000 additional shares of its common stock at the price to the public, less underwriting discounts and commissions.
- 02/11/2021
|
Applied Therapeutics, Inc. Announces Offering of 3,000,000 Shares of Common Stock
- NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it plans to make a public offering of 3,000,000 shares of its common stock, par value $0.0001 per share, in an underwritten registered public offering. The Company expects to grant the underwriters a 30-day option to purchase up to 450,000 additional shares of its common stock.
- 02/10/2021
|
Applied Therapeutics Announces Restart of Pediatric Galactosemia Study
- FDA Clinical Hold Lifted
- 02/01/2021
|
Applied Therapeutics Announces Launch of Galactosemia Awareness and Education Initiative
- NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the launch of Galactosemia Together, the first and only industry-led Galactosemia awareness and education campaign. Developed in partnership with the Galactosemia community, this initiative aims to address gaps in education by providing updated, reliable and credible resources to help connect, educate and support those families impacted by this disease.
- 12/09/2020
|
Applied Therapeutics Announces MRS Data from ACTION-Galactosemia Study
- NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced magnetic resonance spectroscopy (MRS) data on reduction of galactitol levels in the brain of Galactosemia patients treated with AT-007 in the ACTION-Galactodsemia adult study. Overall, plasma reduction in galactitol correlated with brain reduction in galactitol. There were two exceptions, which may have resulted from incomplete peak separation on the MRS scans. At the two doses which demonstrated statistically significant reduction in plasma galactitol, 20 and 40mg/kg, 3 out of 4 patients displayed substantial galactitol reduction ranging from 61.94% to 69.80% reduction from baseline.
- 12/09/2020
|
Applied Therapeutics Announces Presentation of Pre-Clinical Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at the American Heart Association (AHA) Scientific Sessions 2020
- Treatment with AT-001 normalizes cardiac energetics and improves cardiac function in a mouse model of Diabetic Cardiomyopathy (DbCM) Treatment with AT-001 normalizes cardiac energetics and improves cardiac function in a mouse model of Diabetic Cardiomyopathy (DbCM)
- 11/09/2020
|
Irish Airport Retailer ARI Extends Global Footprint To Montenegro And Invests Online
- Aer Rianta International is pushing forwards during the pandemic as a safeguard for the long term, helped by a strong balance sheet, according to its CEO.
- 10/08/2020
|
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors
- INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors
- 08/19/2020
|
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Applied Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Applied Therapeutics, Inc.
- 08/19/2020
|
EQUITY ALERT: ROSEN, A LEADING AND RANKED LAW FIRM, Announces Investigation of Securities Claims Against Applied Therapeutics, Inc. – APLT
- Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT) resulting from allegations that Applied Therapeutics may have issued materially misleading business information to the investing public.
- 08/19/2020
|
SHAREHOLDER ALERT: Block & Leviton LLP Investigating Applied Therapeutics, Inc. for Possible Securities Laws Violations; Shareholders Should Contact the Firm
- BOSTON, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, is investigating whether Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of its executives may be liable for securities fraud. If you purchased or acquired shares of Applied Therapeutics and have questions about your legal rights or possess information relevant to this matter, please contact Block & Leviton attorneys at (617) 398-5600, via email at cases@blockleviton.com, or at https://www.blockleviton.com/cases/aplt. On August 17, 2020, Applied Therapeutics disclosed that the U.S. Food and Drug Administration had placed a partial clinical hold on the Company’s ACTION-Kids study, evaluating the Company’s AT-007 product for the treatment of galactosemia. The FDA cited the need for additional technical information relating to ensuring that each study participant has access to the drug’s benefits. On this news, shares of Applied Therapeutics’ stock fell $3.53 per share, or 12.07%, to close at $25.71.If you purchased or acquired shares of Applied Therapeutics and have questions about your legal rights or possess information relevant to this matter, please contact Block & Leviton attorneys at (617) 398-5600, via email at cases@blockleviton.com, or at https://www.blockleviton.com/cases/aplt.Block & Leviton LLP is a firm dedicated to representing investors and maintaining the integrity of the country’s financial markets. The firm represents many of the nation’s largest institutional investors as well as individual investors in securities litigation throughout the United States. The firm’s lawyers have recovered billions of dollars for its clients.This notice may constitute attorney advertising.CONTACT: BLOCK & LEVITON LLP 260 Franklin St., Suite 1860 Boston, MA 02110 Phone: (617) 398-5600 Email: cases@blockleviton.com SOURCE: Block & Leviton LLP www.blockleviton.com
- 08/18/2020
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT
- Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeutics, Inc. ("GTT" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.
- 08/18/2020
|
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Applied Therapeutics, Inc. (APLT) Investigation
- NEW YORK, NY / ACCESSWIRE / August 18, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc.
- 08/18/2020
|
New Strong Sell Stocks for August 17th
- Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
- 08/17/2020
|
Applied Therapeutics Reports Second Quarter 2020 Financial Results
- NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the second quarter ended June 30, 2020. “The second quarter was an exciting time for the Company, as we continued to advance our late stage programs towards regulatory submission and commercial launch,” said Shoshana Shendelman, PhD, Founder, CEO and Chair of the Board of Applied Therapeutics. “As we move through the rest of the year, we remain focused on our commitment to bringing drugs to patients in urgent need of treatment across multiple diseases, which we believe will ultimately drive shareholder value.”Recent Highlights * Presented Data on AT-007 for Treatment of Galactosemia at the Galactosemia Foundation 2020 Virtual Conference. In July 2020, we presented data and provided an overview of the AT-007 Galactosemia development program at the Galactosemia Foundation 2020 Virtual Conference, a unique platform that brings together patients and families with Galactosemia alongside researchers and physicians. * Announced Start of AT-007 Pediatric Galactosemia Study; Released Additional 40mg/kg Data from Adult Galactosemia Study. June 2020, we announced additional supportive biomarker efficacy and safety data for AT-007 in Galactosemia at 40 mg/kg. The data announced showed once-daily 40 mg/kg AT-007 resulted in plasma galactitol reduction of 55% and a rapid, sustained and statistically significant reduction in galactitol vs. placebo. 40mg/kg was safe and well-tolerated with no drug-related adverse events reported, and no compensatory increase in galactose or other metabolites, such as Gal-1p. We also announced initiation of the AT-007 pediatric trial, ACTION-Galactosemia Kids, in children age 2 to 17. * Presented Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at 2020 American Diabetes Association (ADA) Virtual Scientific Sessions. In June 2020, we presented data at the ADA 80th Scientific Sessions. The presentations included comprehensive data on our aldose reductase inhibitor program and mechanistic data on the role of aldose reductase during hyperglycemia. The presentations included data on the structural basis and rational drug design behind our next generation aldose reductase inhibitors, as well as data elucidating the mechanisms by which AT-001 prevents cellular damage responsible for diabetic complications. * Appointed Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Business Development. In May 2020, we announced the appointment of Dr. Silberstein, formerly Senior Vice President of Corporate Business Development at Allergan plc, as Chief Financial Officer and Head of Business Development. Along with broad corporate strategy and business development skills, Dr. Silberstein brings more than 20 years of investment and capital markets experience to Applied Therapeutics.Financial Results * Cash and cash equivalents and short-term investments totaled $138.5 million as of June 30, 2020 compared with $154.3 million at March 31, 2020. * Research and development expenses for the three months ended June 30, 2020 were $20.8 million, compared to $4.3 million for the three months ended June 30, 2019. For the three months ended June 30, 2020, the increase of $16.5 million was primarily due to an increase in clinical and pre-clinical expense of $7.5 million, primarily related to the progression of the AT-007 ACTION-Galactosemia, and the AT-001 Phase 3 ARISE-HF clinical studies, as well as the commencement of the ACTION-Galactosemia Kids pediatric registrational study; an increase in drug manufacturing and formulation costs of $9.2 million primarily related to the timing of raw material deliveries in support of the 2020 manufacturing campaigns and the completion and release of AT-001 and AT-007 drug product batches; an increase in personnel expenses of $0.2 million due to the increase in headcount in support of our clinical program pipeline; and an increase in regulatory and other expenses of $0.4 million relating to an increase in license fees during the three months ended June 30, 2020. This was partially offset by a decrease in stock-based compensation of $0.8 million due to the increased modification expense recognized during the three months ended June 30, 2019 relating to the acceleration of certain options vesting following the IPO. * General and administrative expenses General and administrative expenses were $7.5 million for the three months ended June 30, 2020, compared to $4.2 million for the three months ended June 30, 2019. For the three months ended June 30, 2020, the increase of $3.3 million was primarily related to the increase in personnel expenses of $1.3 million due to the increase in headcount, $1.1 million related to an increase in legal and professional fees due to increased costs associated with being a public company, $0.8 million related to the establishment of a commercial department, $0.5 million related to increased insurance costs, and $0.3 million in other expenses relating to increased costs of rent and other office expenses. This was partially offset by the decrease of $0.7 million in stock-based compensation expense, due to the additional modification expense recognized in April 2019 for acceleration of certain options vesting following the IPO. * Net loss for the second quarter of 2020 was $28.1 million, or $1.27 per basic and diluted common share, compared to a net loss of $ 8.4 million, or $ 0.60 per basic and diluted common share, for the second quarter 2019.About Applied Therapeutics Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, AT-007, is a novel central nervous system penetrant aldose reductase inhibitor (ARI) for the treatment of Galactosemia, a rare pediatric metabolic disease. The Company initiated a pivotal Phase 1/2 clinical trial in June 2019, read out positive top-line biomarker data in adult Galactosemia patients in January 2020 and announced full data from the trial in April 2020. A pediatric Galactosemia study commenced in June 2020 and is currently ongoing. The Company is also developing AT-001, a novel potent ARI that is being developed for the treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of the heart. The Company initiated a Phase 3 registrational study in DbCM in September 2019. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of diabetic retinopathy, as well as novel dual PI3k inhibitors in preclinical development for orphan oncology indications.Forward-Looking StatementsThis press release contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, included in this press release regarding strategy, future operations, prospects, plans and objectives of management, including words such as “may,” “will,” “expect,” “anticipate,” “plan,” “intend,” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are forward-looking statements. These include, without limitation, statements regarding (i) our plans to submit an NDA for potential approval of AT-007 around year-end 2020, which will also include data from the ACTION-Galactosemia Kids trial and the 90-day safety data in adults with Galactosemia, (ii) the design, scope and results of our clinical trials, (iii) the timing of the initiation and completion of our clinical trials, (iv) the likelihood that data from our clinical trials will support future development of our product candidates, and (v) the likelihood of obtaining regulatory approval of our product candidates and qualifying for any special designations, such as orphan drug designation. Forward-looking statements in this release involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements, and we, therefore cannot assure you that our plans, intentions, expectations or strategies will be attained or achieved.
- 08/11/2020
|
Terns Pharmaceuticals Appoints Senthil Sundaram as Chief Executive Officer, Mark Vignola, Ph.D., as Chief Financial Officer, and Erin Quirk, M.D., as President
- Terns Pharmaceuticals Appoints Senthil Sundaram as CEO, Mark Vignola, Ph.D., as CFO, and Erin Quirk, M.D., as President.
- 08/10/2020
|
Applied Therapeutics Inc. (APLT) Gains But Lags Market: What You Should Know
- In the latest trading session, Applied Therapeutics Inc. (APLT) closed at $25.93, marking a +0.5% move from the previous day.
- 08/03/2020
|
Applied Therapeutics Inc. (APLT) Outpaces Stock Market Gains: What You Should Know
- Applied Therapeutics Inc. (APLT) closed the most recent trading day at $25.74, moving +1.74% from the previous trading session.
- 07/27/2020
|
What to Expect for Applied Therapeutics (APLT) Q2 Earnings
- During Applied Therapeutics' (APLT) upcoming Q2 earnings call, investor focus will be on the company's progress with its novel pipeline candidates targeting areas of high unmet medical need.
- 07/23/2020
|
Zacks.com featured highlights include: Applied Therapeutics, Green Brick Partners, Frequency Therapeutics and Kelly Services
- Zacks.com featured highlights include: Applied Therapeutics, Green Brick Partners, Frequency Therapeutics and Kelly Services
- 07/21/2020
|
Applied Therapeutics to Present Data on AT-007 for Treatment of Galactosemia at the Galactosemia Foundation 2020 Virtual Conference
- NEW YORK, July 17, 2020 -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against.
- 07/17/2020
|
Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?
- Is (APLT) Outperforming Other Medical Stocks This Year?
- 07/10/2020
|
What Type Of Shareholders Own The Most Number of Applied Therapeutics, Inc. (NASDAQ:APLT) Shares?
- If you want to know who really controls Applied Therapeutics, Inc. (NASDAQ:APLT), then you'll have to look at the...
- 07/10/2020
|
Vaccinex (VCNX) Catches Eye: Stock Jumps 8.1%
- Vaccinex (VCNX) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
- 07/07/2020
|
Short Interest in Applied Therapeutics (NASDAQ:APLT) Increases By 11.7%
- Applied Therapeutics (NASDAQ:APLT) was the target of a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 802,800 shares, a growth of 11.7% from the June 15th total of 718,400 shares. Based on an average daily trading volume, of 181,900 shares, the short-interest ratio is […]
- 07/07/2020
|
Magenta (MGTA) Looks Good: Stock Adds 5.2% in Session
- Magenta (MGTA) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
- 07/06/2020
|
Applied Therapeutics Takes Action Against Fraudulent “Short Report” | MarketScreener
|
Applied Therapeutics Takes Action Against Fraudulent “Short Report”
- The fraudulent report includes manipulated company graphs and figures, fraudulent misrepresentation of data, and factual misstatements. Applied Therapeutics will work with law enforcement and regulators to ensure this criminal stock manipulation is prosecuted to the fullest extent of the law. NEW YORK, July 06, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced that it has uncovered fraudulent attempts to manipulate the Applied Therapeutics stock.
- 07/06/2020
|
Applied Therapeutics : Takes Action Against Fraudulent “Short Report” | MarketScreener
|
CRISPR Therapeutics (CRSP) Surges: Stock Moves 6.8% Higher
- CRISPR Therapeutics (CRSP) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
- 07/02/2020
|
Clinics see mixed numbers on 1st day of expanded test criteria
- Different clinics have reported different experiences with the total number of patients who needed to be swabbed yesterday, the first day the expanded testing criteria for Covid-19 were applied.. Read more at straitstimes.com.
- 07/01/2020
|
Ascendis Submits BLA to FDA for TransConhGH in Pediatric GHD
- Ascendis Pharma (ASND) submits BLA to the FDA for TransConhGH for the treatment of pediatric growth hormone deficiency.
- 06/29/2020
|
Sigue habiendo oportunidades en empresas biotecnológicas
- Análisis de Acciones por Salva Fuster cubriendo: AXA SA, Volkswagen AG VZO O.N.. Lea los Análisis de Acciones de Salva Fuster en Investing.com.
- 06/29/2020
|
Hedge Funds Have Never Been This Bullish On Applied Therapeutics, Inc. (APLT)
- In this article we will check out the progression of hedge fund sentiment towards Applied Therapeutics, Inc. (NASDAQ:APLT) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]
- 06/27/2020
|
AquaBounty (AQB) Catches Eye: Stock Jumps 8.9%
- AquaBounty (AQB) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
- 06/24/2020
|
BeyondSpring (BYSI) Catches Eye: Stock Jumps 10.9%
- BeyondSpring (BYSI) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.
- 06/24/2020
|
Who's Who: Genan Ibrahim Omran Al-Omran, director of supply and logistic services at Prince Sultan Military Medical City
- Genan Ibrahim Omran Al-Omran was recently appointed the director of supply and logistic services at Prince Sultan Military Medical City. Al-Omran obtained her bachelor’s degree in pharmaceutical sciences at King Saud University in 2006. In 2011, she attended a foundation course on evidence-based medicine at the National & Gulf Center for Evidence Based Health Practice in Riyadh.
- 06/23/2020
|
Aeglea BioTherapeutics (AGLE) Catches Eye: Stock Jumps 5.1%
- Aeglea BioTherapeutics (AGLE) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
- 06/23/2020
|
Why Applied Therapeutics (APLT) Stock Might be a Great Pick
- Applied Therapeutics (APLT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- 06/22/2020
|
We can maintain a free society while effectively addressing pandemics
- The value of liberty should serve as a beacon to guide government, even in the fog of a crisis.
- 06/22/2020
|
Insider Selling: Applied Therapeutics (NASDAQ:APLT) Director Sells $239,740.76 in Stock
- Applied Therapeutics (NASDAQ:APLT) Director Leslie D. Funtleyder sold 5,402 shares of the firm’s stock in a transaction on Tuesday, June 16th. The shares were sold at an average price of $44.38, for a total value of $239,740.76. Following the transaction, the director now owns 34,148 shares in the company, valued at $1,515,488.24. The sale was […]
- 06/20/2020
|
Selecta Biosciences (SELB) in Focus: Stock Moves 7.4% Higher
- Selecta Biosciences (SELB) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
- 06/19/2020
|
Applied Therapeutics (NASDAQ:APLT) Given Average Recommendation of “Buy” by Brokerages
- Applied Therapeutics (NASDAQ:APLT) has been given an average rating of “Buy” by the nine research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average 12 month price objective among analysts that have issued […]
- 06/19/2020
|
Applied Therapeutics Inc. (APLT) Moves to Strong Buy: Rationale Behind the Upgrade
- Applied Therapeutics Inc. (APLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
- 06/17/2020
|
Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?
- Is (APLT) Outperforming Other Medical Stocks This Year?
- 06/17/2020
|
Applied Therapeutics Announces Start of AT-007 Pediatric Galactosemia Study; Releases Additional 40mg/kg Data from Adult Galactosemia Study
- Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced additional supportive biomarker efficacy and safety data for AT-007 in Galactosemia at 40 mg/kg. “From a scientific perspective, it was important to investigate effects of AT-007 at the higher dose, 40mg/kg, to ensure that we are fully informed on the optimal dose for patients,” said Riccardo Perfetti, MD, PhD, Chief Medical Officer of Applied Therapeutics.
- 06/15/2020
|
Scots mum catches covid19 in hospital while waiting to have both hands amputated
- Joleen Ritchie had already had both of her legs amputated at the beginning of the year after sepsis turned them black.
- 06/13/2020
|
Even the Nicest Country in the World Doesn’t Like China | National Review
- Beijing’s lack of transparency and veracity around its handling of the coronavirus is a factor in this steep decline in favorability.
- 06/11/2020
|
Applied Therapeutics to Present Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at 2020 American Diabetes Association Virtual Scientific Sessions
- Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that three abstracts have been selected, including one oral presentation, at the upcoming American Diabetes Association’s (ADA) 80th Scientific Sessions: A Virtual Experience taking place June 12-16, 2020. The abstracts and presentation include data on the safety and tolerability of Applied Therapeutics’ investigational candidate for Diabetic Cardiomyopathy (DbCM), AT-001, a next generation aldose reductase inhibitor (ARI).
- 06/08/2020
|
What documents are required for Portuguese Golden Visa
- (Partner Content) There is a range of documents that needs to be submitted before applying for the program.
- 06/04/2020
|
Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
- NEW YORK, June 03, 2020 -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against.
- 06/03/2020
|
Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Business Development
- NEW YORK, May 26, 2020 -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated.
- 05/26/2020
|
ThePlace: Al-Ahsa, the verdant land of Saudi Arabia’s Eastern Province
- The verdant, UNESCO-listed lands of Al-Ahsa are home to a natural oasis that is one of the largest in the world. The area is widely considered to have the greenest and most fertile land in Saudi Arabia’s Eastern Province. In addition, amid the date palm groves, farmland and natural springs, visitors can also find historical sites dating back as far as the Neolithic era (between 6,500 and 12,000 years ago).
- 05/15/2020
|
Applied Therapeutics to Present at the UBS Global Healthcare Conference
- Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present at the UBS Global Healthcare Conference on Monday, May 18, 2020 at 10:00 a.m. ET. Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need.
- 05/12/2020
|
8-K: Applied Therapeutics Inc.
- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange...
- 05/11/2020
|
Applied Therapeutics Reports First Quarter 2020 Financial Results
- NEW YORK, May 11, 2020 -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated.
- 05/11/2020
|
Apollo Commercial Real Estate Finance, Inc. (ARI) CEO Stuart Rothstein on Q1 2020 Results - Earnings Call Transcript
- Apollo Commercial Real Estate Finance, Inc. (NYSE:ARI) Q1 2020 Earnings Conference Call May 08, 2020 09:00 AM ET Company Participants Stuart Rothstein - Chief E
- 05/08/2020
|
6 Stock Charts to Watch: ADVM, AKBA, APLT, CLSK, OBSV, TGTX
- Stocks Analysis by Harry Boxer covering: Seattle Genetics Inc, Winnebago Industries Inc, Chembio Diagnostics Inc, TG Therapeutics Inc. Read Harry Boxer's latest article on Investing.com
- 05/06/2020
|
Short Interest in Applied Therapeutics (NASDAQ:APLT) Rises By 7.6%
- Applied Therapeutics (NASDAQ:APLT) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 409,500 shares, an increase of 7.6% from the March 31st total of 380,400 shares. Currently, 3.3% of the shares of the stock are sold short. Based on an average daily volume […]
- 05/01/2020
|
Bank of New York Mellon Corp Grows Position in Applied Therapeutics (NASDAQ:APLT)
- Bank of New York Mellon Corp raised its holdings in Applied Therapeutics (NASDAQ:APLT) by 8.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,402 shares of the company’s stock after purchasing an additional 1,780 shares during the quarter. Bank of New York […]
- 04/28/2020
|
Goldman Sachs: 2 Stocks That Could Climb Over 60%
- When it comes to the current economic landscape, you can either look at the glass half empty or half full. Driven by positive developments in the re-opening of the global economy, U.S. stock futures pointed to opening gains on Monday, but this follows the market’s first week-to-date decline in three weeks thanks to a historic drop in oil prices.This same philosophy applies to the narrowing of market breadth, or how many stocks are participating in a given move in an index. According to Goldman Sachs US equity strategist David Kostin, the S&P; 500 is 17% below its February record, but the median stock trades 28% lower than at its peak. On top of this, 20% of the index’s market capitalization is made up by the five biggest names, surpassing the 18% mark hit in March 2000. Hammond argues that historically, narrow breadth has signaled a substantial market downturn.Other Goldman Sachs strategists, however, see this trend in a more positive light. Goldman Sachs' Ryan Hammond believes that the dispersion of stocks is only going to intensify.“We expect return dispersion will remain elevated in the near term as investors continue to assess the relative 'winners' and 'losers' in the current environment. History shows that correlations typically fall and dispersion rises further as the equity market rebounds out of a bear market,” Hammond explained. As a result, investors have been presented with the greatest opportunity to find outperformers in over ten years, in Hammond’s opinion.With this in mind, we wanted to take a closer look at two stocks Goldman Sachs recently added to its coverage universe. Using TipRanks’ database, we discovered that both Buy-rated tickers boast over 60% upside potential, which could be reason enough to look at the glass half full. Let’s jump right in. Applied Therapeutics (APLT)First up we have Applied Therapeutics, which focuses on cutting down the drug development process by developing assets with increased selectivity and potency, and by utilizing previous research that validates the targeted molecules and pathways. With several promising candidates capable of driving some serious growth, Goldman Sachs believes its long-term growth narrative is strong.Writing for Goldman Sachs, analyst Paul Choi highlights the company's lead candidate, AT-007, whose NDA should be submitted in the second half of 2020, as being a significant component of his bullish thesis. The candidate was designed for use in galactosemia, a rare inherited disorder with 2,800 patients in the U.S., and could see peak sales hit $315 million in the U.S. and $320 million in the EU. “... we think upcoming clinical and regulatory catalysts will further de-risk the asset in 2020 with a likely launch by 2021,” Choi commented.Having said that, Choi thinks investor focus will shift to its AT-001 candidate in diabetic cardiomyopathy (DbCM) with the acceleration of the Phase 3 registrational trial, the results of which are expected to be published in 2021, given the large market opportunity and limited competition. As AT-001 achieved robust efficacy results in the Phase 1/2 trial in type 2 diabetic patients (T2DM), Choi believes there’s a high likelihood of approval, with his estimates putting peak sales at $700 million in the U.S. and $440 million in the EU.Commenting on both assets, Choi stated, “APLT is positioned well to capture share in both therapeutic areas given there are currently no approved therapies for either disease and patients face a high unmet need. Positive data for AT-001 in DbCM could also validate the company’s earlier stage research to address large populations of high unmet need with this asset.”If that’s not enough, Choi cites the AT-003 Phase 1 initiation for diabetic retinopathy in 2020 and the AT-004 Phase 1 initiation for lymphomas in 2020 as being other potential catalysts.To this end, Choi initiated his coverage of this biotech with a Buy rating and $60 price target. Should this target be met, a twelve-month gain of 60% could be in store. (To watch Choi’s track record, click here)Turning now to the rest of the Street, other analysts also take a bullish stance. With 100% Street support, or 4 Buy ratings to be exact, the message is clear: APLT is a Strong Buy. At $63, the average price target is a bit more aggressive than Choi’s and implies 68% upside potential. (See APLT stock analysis on TipRanks)Relmada Therapeutics (RLMD)Another biotech name, Relmada Therapeutics is primarily focused on developing REL-1017, an oral N-methyl-D-aspartate (NMDA) receptor antagonist, for the treatment of major depressive disorder (MDD). Following a positive Phase 2a data readout, Goldman Sachs is onboard.Representing the firm, analyst Ross Weinreb points out that the candidate demonstrated strong efficacy results, with it producing a Montgomery-Asberg Depression Rating Scale (MADRS) delta (placebo-subtracted difference) at Day 14 of -9.4/-10.4, which surpasses what’s witnessed in approved atypical anti-psychotics in adjunct MDD. Additionally, REL-1017 was found to be safe and well tolerated, and didn’t exhibit opioid activity or ketamine-like toxicities that have been seen at the therapeutic doses.As half of depression patients don’t respond to initial anti-depressant therapy, Weinreb sees a large market opportunity, with his estimate for 2032 unadjusted peak sales landing at $2 billion in MDD. “Thus, we see a significant opportunity for a novel therapy with an enhanced clinical profile, such a REL-1017, to enter the market. While we are cognizant of the many players developing therapies in depression, we do not view this as a winner takes all market and note various opportunities exist for multiple therapies across different lines of treatment and settings (i.e monotherapy/acute MDD, TRD),” he explained.To top it all off, the company’s product pipeline includes several other strong assets and REL-1017 could also be used to treat other conditions later down the line. As a result,Weinreb kicked off his RLMD coverage by putting a Buy rating and $63 price target on the stock. This conveys his confidence in RLMD’s ability to climb 75% higher in the next year.Over the past 3 months, only two other analysts have thrown the hat in with a view on the promising drug maker. The two additional Buy ratings provide Relmada with a Strong Buy consensus rating. With an average price target of $59, investors stand to take home a 64% gain, should the target be met over the next 12 months. (See Relmada stock analysis on TipRanks)To find good ideas for biotech stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.
- 04/27/2020
|
G20 ministers discuss COVID-19 impact on tourism
- RIYADH: The Saudi G20 presidency on Friday held a virtual tourism ministers’ meeting to discuss the coronavirus pandemic and tourism. The ministers agreed to explore capacity programs in the industry to help the global economy recover from the pandemic. The meeting, chaired by Saudi Tourism Minister Ahmed Al-Khateeb, discussed the disproportionate and unparalleled impact that the global crisis was having on tourism.
- 04/24/2020
|
Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia Trial
- Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced new data and scientific presentations from the pivotal Phase 2 ACTION-Galactosemia trial. The full study data, originally planned to be presented at the Society for Inherited Metabolic Disorders conference this week, will be available on the company’s website. Slides from the presentation “Development of AT-007 for the treatment of Galactosemia”, presented by Riccardo Perfetti, MD, PhD, Chief Medical Officer of Applied Therapeutics, will be made available today, April 21, at 8:00 a.m. EDT on the Events page under the Investor Relations section of the Applied Therapeutics website at www.appliedtherapeutics.com.
- 04/21/2020
|
Applied Therapeutics (NASDAQ:APLT) Short Interest Down 19.1% in March
- Applied Therapeutics (NASDAQ:APLT) was the target of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 380,400 shares, a decline of 19.1% from the March 15th total of 470,500 shares. Based on an average trading volume of 248,700 shares, the days-to-cover ratio is presently […]
- 04/18/2020
|
Have Insiders Been Buying Applied Therapeutics, Inc. (NASDAQ:APLT) Shares This Year?
- It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
- 04/11/2020
|
Applied Therapeutics (NASDAQ:APLT) Shares Up 9.9%
- Applied Therapeutics (NASDAQ:APLT)’s stock price shot up 9.9% during trading on Monday . The stock traded as high as $35.48 and last traded at $35.01, 115,532 shares were traded during trading. A decline of 53% from the average session volume of 246,267 shares. The stock had previously closed at $31.86. Several brokerages have recently commented […]
- 04/07/2020
|
Applied Therapeutics (NASDAQ:APLT) Stock Rating Upgraded by ValuEngine
- ValuEngine upgraded shares of Applied Therapeutics (NASDAQ:APLT) from a hold rating to a buy rating in a report released on Thursday, ValuEngine reports. A number of other equities analysts also recently issued reports on the company. Citigroup raised their price objective on Applied Therapeutics from $29.00 to $44.00 and gave the stock a buy rating […]
- 04/06/2020
|
Citigroup Inc. Has $36,000 Position in Applied Therapeutics (NASDAQ:APLT)
- Citigroup Inc. increased its holdings in shares of Applied Therapeutics (NASDAQ:APLT) by 1,385.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,322 shares of the company’s stock after buying an additional 1,233 shares during the period. Citigroup Inc.’s holdings in […]
- 04/05/2020
|
Applied Therapeutics (NASDAQ:APLT) Receives Consensus Rating of "Buy" from Analysts
- Applied Therapeutics (NASDAQ:APLT) has received a consensus rating of “Buy” from the eight ratings firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report […]
- 04/05/2020
|
The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation
- Here's a roundup of top developments in the biotech space over the last 24 hours.On a day when the three major averages shed over 4% in reaction to bleak forecasts concerning the COVID-19 pandemic's impact, none of the Nasdaq- or NYSE-listed biotech stocks hit 52-week highs or lows.Stocks In
- 04/02/2020
|
COVID-19 actions - healthcare
- FDA signs off on Emergency Use Authorization for Humanigen's (OTCQB:HGEN) lenzilumab for compassionate use for preventing and treating cytokine storm in severely ill COVID-19 patients.Investigator-ini
- 04/02/2020
|
Applied Therapeutics Announces IND and Investigator-Initiated Studies of AT-001 in Critical COVID-19 Patients
- Applied Therapeutics Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that a COVID-19 IND has been opened with the FDA for AT-001, a novel potent Aldose Reductase inhibitor in global Phase 3 development for Diabetic Cardiomyopathy. Multiple AT-001 investigator-initiated trials are now underway to address acute lung inflammation and cardiomyopathy in critical COVID-19 patients.
- 04/02/2020
|
Applied Therapeutics Reports Fourth Quarter and Year-end 2019 Financial Results
- NEW YORK, March 13, 2020 -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against.
- 03/13/2020
|
Applied Therapeutics to Present at the Barclays Global Healthcare Conference
- Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March 11, 2020 at 1:35 p.m. ET. Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, AT-007, is a novel central nervous system penetrant aldose reductase inhibitor (ARI) for the treatment of Galactosemia, a rare pediatric metabolic disease.
- 03/10/2020
|
Applied Therapeutics Appoints Adam Hansard as Chief Commercial Officer
- Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing novel drug candidates in indications of high unmet medical need, today announced the appointment of Adam Hansard as Chief Commercial Officer. Mr. Hansard brings extensive experience across the biotech and pharmaceutical industry to Applied Therapeutics, ranging from rare disease to large commercial indications. “Adam’s breadth and depth of experience across all aspects of commercialization solidifies our ability to succeed in both near and long-term opportunities,” said Shoshana Shendelman, PhD, Founder, CEO and Chair of the Board of Applied Therapeutics.
- 03/03/2020
|
Applied Therapeutics to Present at the Cowen and Company 40th Annual Health Care Conference
- Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present at the Cowen and Company 40th Annual Health Care Conference on Tuesday, March 3, 2020 at 11:20 a.m. ET in Boston. Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, AT-007, is a novel central nervous system penetrant aldose reductase inhibitor (ARI) for the treatment of Galactosemia, a rare pediatric metabolic disease.
- 02/26/2020
|
The Zacks Analyst Blog Highlights: Onconova Therapeutics, Abeona Therapeutics, Proteostasis Therapeutics, Applied Therapeutics and Ennis
- The Zacks Analyst Blog Highlights: Onconova Therapeutics, Abeona Therapeutics, Proteostasis Therapeutics, Applied Therapeutics and Ennis
- 02/21/2020
|
US Dollar Flexes Muscles Against Other Currencies: 5 Winners
- The US dollar drew support from a healthy domestic economy, and Fed's cautiously optimistic stance about holding interest rates despite the coronavirus outbreak.
- 02/20/2020
|
3 Top Biotech Stocks to Buy in February
- These three clinical-stage biotechs could all double in value before year's end.
- 02/09/2020
|
5 Growth Stocks That Are as Hot as Tesla
- While the record rally in Tesla stock has garnered all the attention over the past six months, these growth stocks have been just as hot.
- 02/07/2020
|
The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 4) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (NASDAQ: ...
- 02/05/2020
|
Daily Insider Ratings Round Up 1/29/20
- Tables of the top insider purchases and sales filed with the SEC on 1/29/20, based on dollar value. Dollar values often do not equate with significance when it
- 01/31/2020
|
The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (NASDAQ: ...
- 01/31/2020
|
Applied Therapeutics, Inc. Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares of Common Stock
- Applied Therapeutics, Inc. (APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it has completed its public offering of 3,152,712 shares of its common stock. The Company intends to use the net proceeds from this offering, together with its existing cash and cash equivalents, to advance AT-007 for the treatment of Galactosemia including pre-launch activities and preparing for a potential commercial launch, to fund clinical development of AT-001 for treatment of Diabetic Cardiomyopathy as well as pre-launch activities, to advance AT-003 for the treatment of diabetic retinopathy through a planned Phase 1 clinical trial; to further develop its pipeline, including other candidates, formulations and derivatives, and to fund other research and development activities, working capital and other general corporate purposes.
- 01/28/2020
|
The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 23) Baudax Bio Inc (NASDAQ: BXRX ) Mesoblast limited (NASDAQ: ...
- 01/24/2020
|
Applied Therapeutics, Inc. Announces Upsizing and Pricing of Public Offering of 2,741,489 Shares of Common Stock
- Applied Therapeutics, Inc. (APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the pricing of its public offering of 2,741,489 shares of its common stock, par value $0.0001 per share, at a price to the public of $45.50 per share. The gross proceeds to the Company from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company, are expected to be approximately $124.7 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 411,223 shares of common stock at the price to the public, less underwriting discounts and commissions.
- 01/24/2020
|
The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 21) Abbott Laboratories (NYSE: ABT ) Apellis Pharmaceuticals ...
- 01/22/2020
|
Applied Therapeutics, Inc. Announces Offering of 1,750,000 Shares of Common Stock
- Applied Therapeutics, Inc. (APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it plans to make a public offering of 1,750,000 shares of its common stock, par value $0.0001 per share, in an underwritten registered public offering. The Company expects to grant the underwriters a 30-day option to purchase up to 262,500 additional shares of common stock. The Company intends to use the net proceeds from this offering, together with its existing cash and cash equivalents, to advance AT-007 for the treatment of Galactosemia including pre-launch activities and preparing for a potential commercial launch, to fund clinical development of AT-001 for treatment of Diabetic Cardiomyopathy as well as pre-launch activities, to advance AT-003 for the treatment of diabetic retinopathy through a planned Phase 1 clinical trial; to further develop its pipeline, including other candidates, formulations and derivatives, and to fund other research and development activities, working capital and other general corporate purposes.
- 01/21/2020
|
The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 15) 10X Genomics Inc (NASDAQ: TXG ) Aimmune Therapeutics ...
- 01/16/2020
|
The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
- The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 14.) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ...
- 01/15/2020
|
Applied Therapeutics Shares March Higher, Can It Continue?
- As of late, it has definitely been a great time to be an investor Applied Therapeutics.
- 01/14/2020
|
Applied Therapeutics Up on Positive Galactosemia Study Data
- Applied Therapeutics (APLT) soars on positive top-line results from the mid-stage study in adult Galactosemia patients on pipeline candidate, AT-007.
- 01/09/2020
|
How Microsoft and DAA use AI to innovate the airport passenger's journey
- AI is allowing Microsoft and the DAA meet demand and improve services at our airports
- 02/21/2019
|
